研究業績 循環器内科 論文発表

    2017 2016
2015 2014 2013 2012
2011 2010 2009 2008
2007 2006 2005 2004

 

 

2017

  1. Kuroda Y, Yuasa S, Watanabe Y, Ito S, Egashira T, Seki T, Hattori T, Ohno S, Kodaira M, Suzuki T, Hashimoto H, Okata S, Tanaka A, Aizawa Y, Murata M, Aiba T, Makita N, Furukawa T, Shimizu W, Kodama I, Ogawa S, Kokubun N, Horigome H, Horie M, Kamiya K, Fukuda K: Flecainide ameliorates arrhythmogenicity through NCX flux in Andersen-Tawil syndrome-iPS cell-derived cardiomyocytes. Biochemistry and Biophysics Reports. 9: 245–256, 2017
  2. Kubo T, Ashihara T, Tsuboutchi T, Horie M: Significance of integrated in silico 2-dimensional transmural ventricular wedge preparation models of human non-failing and failing hearts for evaluation of drug candidates cardiac safety. Journal of Pharmacological and Toxicological Methods. 83:30-41. 2017
  3. Toyota T, Morimoto T, Shiomi H, Ando K, Ono K, Shizuta S, Kato T, Saito N, Furukawa Y, Nakagawa Y, Horie M, Kimura T, CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators: Ad hoc vs. Non-ad hoc Percutaneous Coronary Intervention Strategies in Patients With Stable Coronary Artery Disease. Circ J. 81: 458-467. 2017
  4. Ishikawa T, Ohno S, Murakami T, Yoshida K, Mishima H, Fukuoka T, Kimoto H, Sakamoto R, Ohkusa T, Aiba T, Nogami A, Sumitomo N, Shimizu W, Yoshiura KI, Horigome H, Horie M, Makita N: Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction. Heart Rhythm. 14: 717-724. 2017
  5. Fujii Y, Matsumoto Y, Hayashi K, Ding WG, Tomita Y, Fukumoto D, Wada Y, Ichikawa M, Sonoda K, Ozawa J, Makiyama T, Ohno S, Yamagishi M, Matsuura H, Horie M, Itoh H: Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano-Ward syndrome under double mutations and acquired long QT syndrome under heterozygote. J Cardiol. 70 :74-79. 2017
  6. Yamamoto Y, Makiyama T, Harita T, Sasaki K, Wuriyanghai Y, Hayano M, Nishiuchi S, Kohjitani H, Hirose S, Chen J, Yokoi F, Ishikawa T, Ohno S, Chonabayashi K, Motomura H, Yoshida Y, Horie M, Makita N, Kimura T: Allele-specific Ablation Rescues Electrophysiological Abnormalities in a Human iPS Cell Model of Long-QT Syndrome with a CALM2 Mutation. Human Molecular Genetics. 26 :1670-1677. 2017
  7. Ishibashi K, Aiba T, Kamiya C, Miyazaki A, Sakaguchi H, Wada M, Nakajima I, Miyamoto K, Okamura H, Noda T, Yamauchi T, Itoh H, Ohno S, Motomura H, Ogawa Y, Goto H, Minami T, Yagihara N, Watanabe H, Hasegawa K, Terasawa A, Mikami H, Ogino K, Nakano Y, Imashiro S, Fukushima Y, Tsuzuki Y, Asakura K, Yoshimatsu J, Shiraishi I, Kamakura S, Miyamoto Y, Yasuda S, Akasaka T, Horie M, Shimizu W, Kusano K. Arrhtyhmia risk and β-blocker therapy in pregnant women with long QT syndrome. Heart . 103:1374-1379. 2017
  8. Hayashi H, Wu Q, Horie M: The relationship between J waves and contact of lung cancer with the heart. Ann Noninvasive Electrocardiol. 22. 2017
  9. Yamagata K, Horie M, Ogawa S, Aizawa Y, Ohe T, Yamagishi M, Makita N, Sakurada H, Tanaka T, Shimizu A, Hagiwara N, Kishi R, Nakano Y, Takagi M, Makiyama T, Fukuda K, Watanabe H, Morita H, Kusano K, Hayashi K, Aiba T, Kamakura S, Miyamoto Y, Ogawa H, Shimizu W. Genotype-Phenotype Correlation of SCN5A Mutation for the Clinical and Electrocardiographic Characteristics of Probands With Brugada Syndrome: A Japanese Multicenter Registry.Genotype-Phenotype Correlation of SCN5A Mutation for the Clinical and Electrocardiographic Characteristics of Probands With Brugada Syndrome: A Japanese Multicenter Registry.

    Genotype-Phenotype Correlation of SCN5A Mutation for the Clinical and Electrocardiographic Characteristics of Probands With Brugada Syndrome: A Japanese Multicenter Registry.

    Circulation 135:2255-2270. 2017
  10. Aoki H, Nakamura T, Horie M, Ohno S, Makiyama T, Takemura T: Cardiac conduction defects and brugada syndrome: A Family with overlap syndrome carrying a nonsense SCN5A mutation. Journal of Arrhythmia 33:35-39. 2017
  11. Tomita Y, Nakae I, Hayashi H, Ozawa T, Horie M: Utility of phase standard deviation and histogram bandwidth by "Heart Function View" analysis as a clinical indicator of heart failure. Annals of Nuclear Medicine (in press)
  12. Taniguchi T, Shiomi H, Morimoto T, Watanabe H, Ono K, Shizuta S, Kato T, Saito N, Kaji S, Ando K, Kadota K, Furukawa Y, Nakagawa Y, Horie M, Kimura T: Incidence and Prognostic Impact of Heart Failure Hospitalization During Follow-up after Primary Percutaneous Coronary Intervention in ST-segment Elevation Myocardial Infarction. American Journal of Cardiology 119:1729-1739. 2017
  13. Aonuma K, Shiga T, Atarashi H, Doki K, Echizen H, Hagiwara N, Hasegawa J, Hayashi H, Hirao K, Ichida F, Ikeda T, Maeda Y, Matsumoto N, Sakaeda T, Shimizu W, Sugawara M, Totsuka K, Tsuchishita Y, Ueno K, Watanabe E, Hashiguchi M, Hirata S, Kasai H, Matsumoto Y, Nogami A, Sekiguchi Y, Shinohara T, Sugiyama A, Sumitomo N, Suzuki A, Takahashi N, Yukawa E, Homma M, Horie M, Inoue H, Ito H, Miura T, Ohe T, Shinozaki K, Tanaka K; Japanese Circulation Society and the Japanese Society of Therapeutic Drug Monitoring Joint Working Group: Guidelines for Therapeutic Drug Monitoring of Cardiovascular Drugs Clinical Use of Blood Drug Concentration Monitoring (JCS 2015) - Digest Version. Circulation Journal 81: 581-612. 2017
  14. Kimura Y, Noda T, Matsuyama T, Otsuka Y, Kamakura T, Wada M, Ishibashi K, Inoue Y, Miyamoto K, Okamura H, Nagase S, Aiba T, Kamakura S, Noguchi T, Anzai T, Satomi K, Wada Y, Ohno S, Horie M, Shimizu W, Yasuda S, Shimokawa H, Kusano K. Heart failure in patients with arrhythmogenic right ventricular cardiomyopathy: what are the risk factors? International Journal of Cardiology 241:288-294. 2017
  15. Hayano M, Makiyama T, Kamakura T, Watanabe H, Sasaki K, Funakoshi S, Wuriyanghai Y, Nishiuchi S, Harita T, Yamamoto Y, Kohjitani H, Hirose S, Yokoi F, Chen J, Baba O, Horie T, Chonabayashi K, Ohno S, Toyoda F, Yoshida Y, Ono K, Horie M, Kimura T: The Development of a Patient-Derived Induced Pluripotent Stem Cell Model for the Investigation of SCN5A-D1275N-Related Cardiac Sodium Channelopathy. Circulation Journal (in press)
  16. Turker I, Ai T, Itoh H, Horie M. Drug-induced fatal arrhythmias: Acquired long QT and Brugada syndromes. Pharmacology and Therapeutics 176:48-59. 2017
  17. Horie M. Long QT syndrome presents not only as QT prolongation but also as abnormal T-wave morphology. Heart Rhythm 14:1171-1172.  2017
  18. Ueshima S, Hira D, Fujii R, Kimura Y, Tomitsuka C, Yamane T, Tabuchi Y, Ozawa T, Itoh H, Horie M, Terada T, Katsura T. Impact of ABCB1, ABCG2, and CYP3A5 polymorphisms on plasma trough concentrations of apixaban in Japanese patients with atrial fibrillation. Pharmacogenetics and Genomics 27:329-336. 2017
  19. Suzuki S, Arima H, Miyazaki S, Fujiyoshi A, Kadota A, Takashima N, Hisamatsu T, Kadowaki S, Zaid M, Torii S, Horie M, Murata K, Miura K, Ueshima H, for the SESSA Research Group. Association between Sleep Duration and Subclinical Atherosclerosis in a General Population of Japanese Men: the Shiga Epidemiological Study of Subclinical Atherosclerosis (SESSA). Journal of Atherosclerosis and Thrombosis. 27:329-336. 2017
  20. Shirai Y, Goya M, Ohno S, Horie M, Doi S, Isobe M, Hirao K: Elimination of ventricular arrhythmia in catecholaminergic polymorphic ventricular tachycardia by targeting “catecholamine-sensitive area”: a dominant-subordinate relationship between origin sites of bidirectional ventricular premature contractions. Pacing Clin Electrophysiol. 40:600-604. 2017
  21. Sonoda K, Ohno S, Otsuki S, Kato K, Yagihara N, Watanabe H, Makiyama T, Minamino T, Horie M: Quantitative analysis of PKP2 and neighbouring genes in a patient with arrhythmogenic right ventricular cardiomyopathy caused by heterozygous PKP2 deletion. Europace 19:644-650. 2017
  22.  Fujii Y, Matsumoto Y, Hayashi K, Ding WG, Tomita Y, Fukumoto D, Wada Y, Ichikawa M, Sonoda K, Ozawa J, Makiyama T, Ohno S, Yamagishi M, Matsuura H, Horie M, Itoh H: Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano-Ward syndrome under double mutations and acquired long QT syndrome under heterozygote. J Cardiol 70:74-79. 2017
  23. Shirai Y, Goya M, Ohno S, Horie M, Doi S, Isobe M, Hirao K: Elimination of ventricular arrhythmia in catecholaminergic polymorphic ventricular tachycardia by targeting “catecholamine-sensitive area”: a dominant-subordinate relationship between origin sites of bidirectional ventricular premature contractions. PACE40:600-604. 2017
  24. Hata J, Nagai A, Hirata M, Kamatani Y, Tamakoshi A, Yamagata Z, Muto K, Matsuda K, Kubo M, Nakamura Y; Biobank Japan Cooperative Hospital Group (Collaborators:Ashihara T), Kiyohara Y, Ninomiya T; Collaborator. Risk prediction models for mortality in patients with cardiovascular disease: The BioBank Japan project. J Epidemiol. 27: S71-S76. 2017
  25. Suzuki S, Arima H, Miyazaki S, Fujiyoshi A, Kadota A, Takashima N, Hisamatsu T, Kadowaki S, Zaid M, Torii S, Horie M, Murata K, Miura K, Ueshima H; SESSA Research Group. Self-reported Sleep Duration and Subclinical Atherosclerosis in a General Population of Japanese Men. Journal of Atheroscler Thromb (in press)
  26. Seki A, Ishikawa T, Daumy X, Mishima H, Barc J, Sasaki R, Nishii K, Saito K, Urano M, Ohno S, Otsuki S, Kimoto H, Baruteau AE, Thollet A, Fouchard S, Bonnaud S, Parent P, Shibata Y, Perrin JP, Le Marec H, Hagiwara N, Mercier S, Horie M, Probst V, Yoshiura KI, Redon R, Schott JJ, Makita N. Progressive Atrial Conduction Defects Associated With Bone Malformation Caused by a Connexin-45 Mutation. J Am Coll Cardiol. 70:358-370. 2017
  27. Nishiuchi S, Makiyama T, Aiban T, Nakajima K, Hirose S, Kohjitani H, Yamamoto Y, Harita T, Hayano M, Wuriyanghai Y, Chen J, Sasaki K, Yagihara N, Ishikawa T, Onoue K, Murakoshi N, Watanabe I, Ohkubo K, Watanabe H, Ohno S, Doi T, Shizuta S, Minamino T, Saito Y, Oginosawa Y, Nogami A, Aonuma K, Kusano K, Makita N, Shimizu W, Horie M, Kimura T. Gene-based Risk Stratification for Cardiac Disorders in LMNA Mutation Carriers. Circulation Cardiovascular Genetics (in press)
  28. Li M, Kanda Y, Ashihara T, Sasano T, Nakai Y, Kodama M, Hayashi E, Sekino Y, Furukawa T, Kurokawa J: Overexpression of KCNJ2 in induced pluripotent stem cell-derived cardiomyocytes for the assessment of QT-prolonging drugs. J Pharmacol Sci. 134:75-85. 2017
  29. Inada S, Shibata N, Iwata M, Haraguchi R, Ashihara T, Ikeda T, Mitsui K, Dobrzynski H,Boyett MR, Nakazawa K: Simulation of ventricular rate control during atrial fibrillation using ionic channel blockers. J Arrhythm 33:302-309. 2017
  30. Toyota T, Morimoto T, Shiomi H, Yamaji K, Ando K, Ono K, Shizuta S, Saito N, Kato T, Kaji S, Furukawa Y, Nakagawa Y, Kadota K, Horie M, Kimura T, CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Single-session Versus Staged Procedures for Elective Multi-vessel Percutaneous Coronary Intervention: Observational Study. Heart (in press)

 

このページの先頭へ

 

2016

  1. Ichikawa M, Ohno S, Fujii Y, Ozawa J, Sonoda K, Fukuyama M, Kato K, Kimura H, Itoh H, Hayashi H, Horie M: Multigenerational inheritance of long QT syndrome type 2 in a Japanese family. Internal Med. 55: 259-262. 2016
  2. Chen J, Makiyama T, Wuriyanghai Y, Ohno S, Sasaki K, Hayano M, Harita T, Nishiuchi S, Yamamoto Y, Ueyama T, Shimizu A, Horie M, Kimura T: Cardiac sodium channel mutation associated with epinephrine-induced QT prolongation and sinus node dysfunction. Heart Rhythm. 13: 289-298.  2016
  3. Ueshima H, Kadowaki T, Hisamatsu T, Fujiyoshi A, Miura K, Ohkubo T, Sekikawa A, Kadota A, Kadowaki S, Nakamura Y, Miyagawa N, Okamura T, Kita Y, Takashima N, Kashiwagi A, Maegawa H, Horie M, Yamamoto T, Kimura T, Kita T, for the ACCESS and SESSA Research Group: Lipoprotein-associated phospholipase A2 related to the risk of subclinical atherosclerosis independent of small low density lipoprotein particles in a general Japanese population.Athelosclerosis. 246: 141-147.  2016
  4. Kaitani K, Inoue k, Kobori A, Nakazawa Y, Ozawa T, Kurotobi Toshiya, Morishima I, Miura F, Watanabe T, Masuda M, Naito M, Fujimoto H, Nishida T, Furukawa Y, Shirayama T, Tanaka M, Okajima K, Yao T, Egami Y, Satomi K, Noda T, Miyamoto K, Haruna T, Kawaji T, Yoshizawa T, Toyota T, Yahata M, Nakai K, Sugiyama H, Higashi Y, Ito M, Horie M, Kusano K, Shimizu W, Kamakura S, Morimoto T, Kimura T, on behalf of the EAST-AF Trial Investigators: Efficacy of Antiarrhythmic drugs Short-Term use after catheter ablation for Atrial Fibrillation (EAST-AF) trial. European Heart Journal.37: 610-618.  2016
  5. Wada Y, Aiba T, Tsujita Y, Itoh H, Wada M, Nakajima I, Ishibashi K, Okamura H, Miyamoto K, Noda T, Sugano Y, Kanzaki, Toshihisa Anzai, Kengo Kusano H, Yasuda S, Horie M, Ogawa H: Practical Applicability of Landiolol, an Ultra-short-acting β1-selective Blocker, for Rapid Atrial and Ventricular Tachyarrhythmias with Left Ventricular Dysfunction. Journal of Arrhythmia. 82–88. 2016
  6. Toyota T, Shiomi H, Taniguchi T, Morimoto T, Furukawa Y, Nakagawa Y, Horie M, Kimura T: Culprit vessel only versus staged multivessel percutaneous coronary intervention strategies in patients with multivessel coronary artery disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Circulation Journal 80: 371-378. 2016.
  7. Baruteau AE, Perryd JC, Sanatanie S, Horie M, Walshg EP, Dubin AM: Evaluation and management of bradycardia in neonates and children. European Journal of Pediatrics. 175: 151-161. 2016
  8. Zaid M, Miura K, Fujiyoshi A, Abbott RD, Hisamatsu T, Kadota A, Arima H, Kadowaki S, Torii S, Miyagawa N, Suzuki S, Takashima N, Ohkubo T, Sekikawa A, Maegawa H, Horie M, Nakamura Y, Okamura T, Ueshima H, for the SESSA Research group: Associations of serum LDL particle concentration with carotid intima-media thickness and coronary artery calcification. Journal of Clinical Lipidology. 10: 1195-1202. 2016
  9. Freyermuth F, Rau F, Kokunai Y, Linke T, Sellier C, Nakamori M3 Kino Y, Arandel L, Jollet A, Thibault C, Philipps M, Vicaire S, Jost B, Udd B, Day JW, Duboc D, Wahbi K, Matsumura T, Fujimura H, Mochizuki H, Deryckere F, Kimura T, Nukina N, Ishiura S, Lacroix V, Campan-Fournier A, Navratil V, Chautard E, Auboeuf D, Horie M, Imoto K, Lee KY, Swanson MS, Lopez de Munain A, Inada S, Itoh H, Nakazawa K, Ashihara T, Wang E, Zimmer T, Furling D, Takahashi MP, Charlet-Berguerand N: Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy . Nature Communications. 7: 11067. 2016
  10. Hayashi K, Konno T, Fujino N, Itoh H, Sakata K, Tada H, Tsuda T, Nagata Y, Teramoto R, Tanaka Y, Fujii Y, Imi-Hashida Y, Saito T, Kawashiri M, Ohta K, Horie M, Yamagishi M: Impact of Updated Diagnostic Criteria for Long QT Syndrome on Clinical Detection of Diseased Patients: Results from Study of Patients Carrying Gene Mutations. JACC Clin Electrophysiol. 2: 279-287. 2016
  11. Yamazoe M, Hisamatsu T, Miura K, Kadowaki S, Zaid M, Kadota A, Torii S, Miyazawa I, Fujiyoshi A, Abbott RD, Arima H, Sekikawa A, Maegawa H, Horie M, Ueshima H, for the SESSA Research Group: Relationship of insulin resistance to prevalence and progression of coronary artery calcification beyond metabolic syndrome components: Shiga Epidemiological Study of Subclinical Atherosclerosis (SESSA). Arteriosclerosis, Thrombosis, and Vascular Biology 36: 1703-1708. 2016
  12. Itoh H, Crotti L, Aiba T, Spazzplini C, Denjoy I, Fressart V, Hayashi K, Nakajima T, Ohno S, Makiyama T, Wu J, Hasegawa K, Mastantuono E, Dagradi F, Pedrazzini M, Yamagishi M, Berthet M, Murakami Y, Shimizu W, Guicheney P, Schwartz PJ, Horie M:  The Genetics Underlying Acquired Long QT Syndrome. Impact on genetic screening. European Heart Journal . 37: 1456-1464. 2016
  13. Nakatsuma K, Shiomi H, Morimoto T, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Yamamoto T, Suwa S, Horie M, Kimura T, on behalf of the CREDO-Kyoto AMI investigators: Inter-facility Transfer versus Direct Admission in Patients with ST-segment Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Circulation Journal 80: 477-484. 2016
  14. Kawata H, Ohno S, Sumitomo N, Funasako M, Kamakura T, Nakajima I, Sakaguchi H, Miyazaki A, Miyamoto K, Inoue YY, Okamura H, Noda T, Aiba T, Kusano KF, Kamakura S, Horie M, Shimizu W: Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) associated with Ryanodine Receptor (RyR2) gene mutations: Long term prognosis and utility of an exercise stress test after initiation of medical treatment. Circulation Journal 80: 1907-1915. 2016
  15. Fukuyama M, Ohno S, Makiyama T, Horie M: Novel SCN10A Variants Associated with Brugada Syndrome.
    Europace 18: 905-911. 2016.
  16. Horie M: Molecular Genetics Have Opened a New Era for Arrhythmia Research, but also Pandora’s Box? Journal of Arrhythmia 32: 313-314. 2016
  17. Juang J-M, Horie M: Genetics of Brugada syndrome. Journal of Arrhythmia 32: 418-425. 2016
  18. Ohno S. The genetic background of arrhythmogenic right ventricular cardiomyopathy. Journal of Arrhythmia 32: 398-403. 2016
  19. Fujii Y, Itoh H, Ohno S, Murayama T, Kurebayashi N, Aoki H, Blancard M, Nakagawa Y, Yamamoto S, Matsui Y, Ichikawa M, Sonoda K, Ozawa T, Ohkubo K, Watanabe I, Guicheney P, Horie M: A type 2 ryanodine receptor variant associated with reduced Ca2+ release and short-coupled torsade de pointe ventricular arrhythmia. Heart Rhythm 14: 98-107 2016
  20. Yagihara N, Watanabe H, Barnett P, Duboscq-Bidot L, Thomas AC, Yang P, Ohno S, Hasegawa K, Kuwano R, Chatel S, Redon R, Schott JJ, Probst V, Koopmann TT, Bezzina CR, Wilde AA, Nakano Y, Aiba T, Miyamoto Y, Kamakura S, Darbar D, Donahue BS, Shigemizu D, Suda M, Sato A, Minamino T, Endo N, Shimizu W, Horie M, Roden DM, Makita N: Variants in the SCN5A promoter associated with various arrhythmia phenotypes.  JAHA. 5(9). 2016
  21. Ozawa J, Ohno S, Hisamatsu T, Itoh H, Makiyama T, Suzuki H, Saitoh A, Horie M: Pediatric cohort with long QT syndrome: KCNH2 mutation carriers have late onset but severe symptoms. Circulation Journal 80: 696-702. 2016.
  22. Hisamatsu T, Miura K, Arima H, Kadota A, Kadowaki S, Torii S, Suzuki S, Miyagawa N, Sato A, Yamazoe M, Fujiyoshi A, Ohkubo T, Yamamoto T, Murata K, Abbott RD, Sekikawa A, Horie M, Ueshima H, for the SESSA Research Group: Smoking, Smoking Cessation, and Measures of Subclinical Atherosclerosis in Multiple Vascular Beds in Japanese Men. JAHA 5(9). 2016
  23. Turker I, Makiyama T, Vatta M, Sohma Y, Itoh H, Ueyama T, Shimizu A, Ai T, Horie M: A novel SCN5A variant associate with drug-induced Brugada Syndrome Plos ONE 11: e0161872. 2016
  24. Antzelevitch C, Yan GX, Ackerman MJ, Borggrefe M, Corrado D, Guo J, Gussak I, Hasdemir C, Horie M, Huikuri H, Ma C, Morita H, Nam GB, Sacher F, Shimizu W, Viskin S, Wilde AA: J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge. Heart Rhythm. 13:e295-324. 2016
  25. Watanabe T, Ohno S, Shirai M, Endoh A, Hongo T, Ueta I, Yoshimoto J: Inherited catecholaminergic polymorphic ventricular tachycardia due to RYR2 mutation. Pediatr Int. 58: 512-515. 2016
  26. Kubo T, Ashihara T, Tsuboutchi T, Horie M: Significance of integrated in silico 2-dimensional transmural ventricular wedge preparation models of human non-failing and failing hearts for evaluation of drug candidates cardiac safety. Journal of Pharmacological and Toxicological Methods. 18: 30-41. 2016
  27. Hasegawa K, Watanabe H, Hisamatsu T, Ohno S, Itoh H, Ashihara T, Hayashi H, Makiyama T, Minamino T, Horie M: Early repolarization and risk of arrhythmia events in long QT syndrome. International Journal of Cardiology. 223: 540-542. 2016
  28. Ichikawa M, Aiba T, Ohno S, Shigemizu D, Ozawa J, Sonoda K, Fukuyama M, Itoh H, Minamoto Y, Tsunoda T, Makiyama T, Tanaka T, Shimizu W, Horie M: Phenotypic variability of ANK2 mutations in patients with inherited primary arrhythmia syndromes. Circulation Journal. 80: 2435- 2442. 2016
  29. Sasaki K, Makiyama T, Yoshida Y, Wuriyanghai Y, Kamakura T, Nishiuchi S, Hayano M, Harita T, Yamamoto Y, Kohjitani H, Hirose S, Chen J, Itoh H, Kawamura M, Ohno S, Takeuchi A, Matsuoka S, Miura M, Sumitomo N, Horie M, Yamanaka S, Kimura T: Patient-specificHuman Induced Pluripotent Stem Cell Model Assessed with Electrical PacingValidatesS107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia. PlosOne 11: e0164795. 2016
  30.  Itoh H, Berthet M, Fressart V, Denjoy I, Maugenre S, Klug D, Mizusawa Y, Makiyama T, Hofman N, Shimizu W, Wilde AAM, Schulze-Bahr E, Horie M, Tezenas du Montcel S, Guicheney P: Asymmetry of parental origin in Long QT syndrome. Preferential maternal transmission of KCNQ1 variants linked to channel dysfunction European Journal of Human Genetics. 24: 1160-1166. 2016
  31. Okata S, Yuasa S, Suzuki T, Ito S, Makita N, Yoshida T, Li M, Kurokawa J, Seki T, Egashira T, Aizawa Y, Kodaira M, Motoda C, Yozu G, Shimojima M, Hayashiji N, Hashimoto H, Kuroda Y, Tanaka A, Murata M, Aiba T, Shimizu W, Horie M, Kamiya K, Furukawa T, Fukuda K: Embryonic type Na+ channel β-subunit, SCN3B masks the disease phenotype of Brugada syndrome. Sci Rep. 6: 34198 2016
  32. Hayashi H, Iwai K, Tobita R, Matsumoto T, Horie M: The relationship between skeletal muscle and ventilatory response to exercise in myocardial infarction. IJC Metabolic and Endocrine 12: 14-18 2016
  33. Antzelevitch C, Yan GX, Ackerman MJ, Borggrefe M, Corrado D, Guo J, Gussak I, Hasdemir C, Horie M, Huikuri HV, Ma C, Morita H, Nam GB, Sacher F, Shimizu W, Viskin S, Wilde AAM: J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge: Endorsed by the Asia Pacific Heart Rhythm Society (APHRS), the European Heart Rhythm Association (EHRA), the Heart Rhythm Society (HRS), and the Latin American Society of Cardiac Pacing and Electrophysiology (Sociedad Latinoamericana de Estimulacifin Cardiaca y Electrofsiologia [SOLAECE]). Europace 13: euw235 2016
  34. Antzelevitch C, Yan G-X, Ackerman M-J, Borggrefe M, Corrado D, Guo J, Gussak I, Hasdemir C, Horie M, Huikuri H, Ma C, Morita H, Nam G-B, Sacher F, Shimizu W, Viskin S, Wilde AAM: J-wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge. J Arrhythm. 32: 315-339. 2016
  35. Wu J, Ding W-G, Horie M. Molecular pathogenesis of long QT syndrome type 1. Journal of Arrhythmia 32: 381-388. 2016
  36. Okamura T, Miura K, Sawamura T, Kadota A, Hisamatsu T, Fujiyoshi A, Miyamatsu N, Takashima N, Miyagawa N, Kadowaki T, Ohkubo T, Murakami Y, Nakamura Y, Ueshima H; SESSA Research Group: Serum level of LOX-1 ligand containing ApoB is associated with increased carotid intima-media thickness in Japanese community-dwelling men, especially those with hypercholesterolemia LOX-1 ligand and IMT in Japanese. J Clin Lipidol. 10 :172-80. 2016
  37. Uehara A, Murayama T, Yasukochi M, Fill M, Horie M, Okamoto T, Matsuura Y, Uehara K, Fujimoto T, Sakurai T, Kurebayashi N: Extensive Ca2+ leak through K4750Q cardiac ryanodine receptors
    caused by cytosolic and luminal Ca2+ hypersensitivity. Journal of General Physiology 149:199-218 2016
  38. Hayashi H, Wu Q, Horie M. Association between progressive intraventricular conduction disturbance and cardiovascular events. PLOS ONE 12: 14-18. 2016
  39. Sonoda K, Watanabe H, Hisamatsu T, Ashihara T, Ohno S, Hayashi H, Horie M, Minamino T: High frequency of early repolarization and Brugada-type electrocardiograms in hypercalcemia. Ann Noninvasive Electrocardiol. 21:30-40. 2016
  40. Aizawa Y, Takatsuki S, Kaneko Y, Noda T, Katsumata Y, Nishiyama T, Kimura T, Nishiyama N, Fukumoto K, Niwano S, Kurita T, Mitsuhashi T, Kamakura S, Shimizu A, Horie M, Aizawa Y, Fukuda K. Comparison of circadian, weekly, and seasonal variations of electrical storms and single events of ventricular fibrillation in patients with Brugada syndrome. Int J Cardiol Heart Vasc. 11:104-110. 2016

 

 

このページの先頭へ

 

 

2015

  1. Hisamatsu T, Miura K, Fujiyoshi A, Okamura T, Ohkubo T, Nagasawa SY, Horie M, Okayama A, Ueshima H, for the NIPPON DATA80 Research Group: Long-term outcomes associated with prolonged PR interval in the general Japanese population. International Journal of Cardiology. 184: 291-293, 2015.
  2. Miyamoto K, Aiba T, Kimura H, Hayashi H, Ohno S, Yasuoka C, Tanioka Y, Tsuchiya 5, Yoshida Y, Hayashi H, Tsuboi I, Nakajima I, Ishibashi K, Okamura H, Noda T, Ishihara M, Anzai T, Yasuda S, Miyamoto Y, Kamakura S, Kusano K, Ogawa H, Horie M, Shimizu W: Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutation. Heart Rhythm 12: 596-603, 2015
  3. Hasegawa K, Ohno S, Kimura H, Itoh H, Makiyama T, Yoshida Y, Horie M: Mosaic KCNJ2 Mutation in Andersen-Tawil syndrome: Targeted Deep Sequencing is Useful for the Detection of Mosaicism. Clinical Genetics 87: 279-283. 2015
  4. Wada Y, Aiba T, T Matsuyama, I Nakajima, Ishibashi K, Miyamoto K, Yamada Y, Okamura H, Noda T, Satomi K, Morita Y, Kanzaki H, Kusano K, Anzai T, Kamakura S, Ishibashi-Ueda H, Shimizu Wataru, Horie M, Yasuda S, Ogawa H: Clinical and Pathological Impact of Tissue Fibrosis on Lethal Arrhythmic Events in Hypertrophic Cardiomyopathy Patients With Impaired Systolic Function. Circulation Journal 79:1733-1741, 2015
  5. Itoh H,Dochi K,Shimizu W,Ohno S,Aiba T,Kimura H,Kato K,Fukuyama M,Hasegawa K,Schulze-Bahr E,Guicheney P,Horie M. A common mutation of long QT Syndrome type 1 in Japan. Circulation Journal. 79: 2026-2030. 2015
  6. Ohno S,Hasegawa K,Horie M.Gender differences in the inheritance mode of RYR2 mutations in catecholaminergic polymorphic ventricular tachycardia patients. PLOS One. 10:e0131517. 2015
  7. Sawayama Y, Itoh H, Sakai H, Horie M. Löffler endocarditis and lacking heart. Intern Med. 54, 3093, 2015 
  8. Torii S, Arima H, Ohkubo T, Fujiyoshi A, Kadota A, Takashima N, Kadowaki S, Hisamatsu T, Saito Y, Miyagawa N, Zaid M, Murakami Y, Abbott RD, Horie M, Miura K, Ueshima H. Association between Pulse Wave Velocity and Coronary Artery Calcification in Japanese men: the Shiga Epidemiological Study of Subclinical Atherosclerosis . Journal of Atherosclerosis and Thrombosis; 22(12): 1266-1277. 2015
  9. Watanabe H, Shiomi H, Nakatsuma K, Morimoto T, Taniguchi T, FurukawaY, Nakagawa Y, Horie M, Kimura T; CREDO‐Kyoto AMI investigators,Kimura T, Sakata R, Marui A, Matsuda M, Mitsuoka H, Onoe M, NakagawaY, Yamanaka K, Fujiwara H, Takatsu Y, Ohno N, Nohara R, Murakami T,Takeda T, Nobuyoshi M, Iwabuchi M, Hanyu M, Tatami R, Matsushita T,Shirotani M, Nishiwaki N, Kita T, Furukawa Y, Okada Y, Kato H, EizawaH, Is K, Tanaka M, Nakayama S, Lee JD, Nakano A, Koshiji T, Morioka K,Takizawa A, Shimamoto M, Yamazaki F, Takahashi M, Nishizawa J, HorieM, Takashima H, Tamura T, Aota M, Takahashi M, Tabata T, Tei C,Hamasaki S, Imoto Y, Yamamoto H, Kambara H, Doi O, Matsuda K, Nara M,Mitsudo K, Kadota K, Komiya T, Miki S, Mizoguchi T, Nakajima H, OgawaH, Sugiyama S, Kawasuji M, Moriyama S, Hattori R, Aoyama T, Araki M,Suwa S, Tanbara K, Kitagawa K, Yamauchi M, Okamoto N, Fujino Y, TezukaS, Saeki A, Hanazawa M, Sato Y, Hibi C, Sasae H, Takinami E, Uchida Y,Yamamoto Y, Nishida S, Yoshimoto M, Maeda S, Miki I, Minematsu S, AbeM, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Tokushige A, NatsuakiM, Nakajima T: Clinical Efficacy of Thrombus Aspiration on 5-Year Clinical Outcomes in Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention. J Am Heart Assoc. 4: e001962. 2015
  10. Watanabe H, Morimoto T, Natsuaki M, Furukawa Y, Nakagawa Y, Kadota K, Yamaji K, Ando K, Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Tamura T, Shirotani M, Miki S, Matsuda M, Takahashi M, Ishii K, Tanaka M, Aoyama T, Doi O, Hattori R, Kato M, Suwa S, Takizawa A, Takatsu Y, Shinoda E, Eizawa H, Takeda T, Lee JD, Inoko M, Ogawa H, Hamasaki S, Horie M, Nohara R, Kambara H, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kastrati A, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Antiplatelet therapy discontinuation and the risk of serious cardiovascular events after coronary stenting: observations from the CREDO-Kyoto Registry Cohort-2. PLoS One. 10: e0124314. 2015
  11. Hayashi H, Horie M.The association of J wave and ventricular tachycardia before device implantation with device interventions for ventricular tachyarrhythmia. J Electrocardiol. 48: 721-728. 2015
  12. Kobori A, Shizuta S, Inoue K, Kaitani K, Morimoto T, Nakazawa Y, Ozawa T, Kurotobi T, Morishima I, Miura F, Watanabe T, Masuda M, Naito M, Fujimoto H, Nishida T, Furukawa Y, Shirayama T, Tanaka M, Okajima K, Yao T, Egami Y, Satomi K, Noda T, Miyamoto K, Haruna T, Kawaji T, Yoshizawa T, Toyota T, Yahata M, Nakai K, Sugiyama H, Higashi Y, Ito M, Horie M, Kusano K, Shimizu W, Kamakura S, Kimura T, on behalf of the UNDER-ATP Trial Investigators:Adenosine triphosphate-guided pulmonary vein isolation for atrial fibrillation: the UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) trial. European Heart Journal. 36: 3276-3287. 2015
  13. Kato K,  Takahashi N, Fujii Y, Umehara A, Nishiuchi S, Makiyama T, Ohno S, Horie M. LMNA Cardiomyopathy Detected in Japanese Arrhythmogenic Right Ventricular Cardiomyopathy Cohort. Journal of Japanese College of Cardiology. S0914-5087(15)00355-X. 2015
  14. Zaid M, Miura K, Fujiyoshi A, Abbott RD, Hisamatsu T, Kadota A, Arima H, Kadowaki S, Torii S, Miyagawa N, Suzuki S, Takashima N, Ohkubo T, Sekikawa A, Maegawa H, Horie M, Nakamura Y, Okamura T, Ueshima H, for the SESSA Research group. Associations of serum LDL particle concentration with carotid intima-media thickness and coronary artery calcification. Journal of Clinical Lipidology 10(5):1195-1202. 2015
  15. Hayashi H, Horie M. Biphasic P wave in inferior leads and the development of atrial fibrillation. J Arrhythm. 31: 376-378. 2015
  16. Kaitani K, Inoue k, Kobori A, Nakazawa Y, Ozawa T, Kurotobi Toshiya, Morishima I, Miura F, Watanabe T, Masuda M, Naito M, Fujimoto H, Nishida T, Furukawa Y, Shirayama T, Tanaka M, Okajima K, Yao T, Egami Y, Satomi K, Noda T, Miyamoto K, Haruna T, Kawaji T, Yoshizawa T, Toyota T, Yahata M, Nakai K, Sugiyama H, Higashi Y, Ito M, Horie M, Kusano K, Shimizu W, Kamakura S, Morimoto T, Kimura T, on behalf of the EAST-AF Trial Investigators: Efficacy of Antiarrhythmic drugs Short-Term use after catheter ablation for Atrial Fibrillation (EAST-AF) trial. European Heart Journal 37:610-618. 2015
  17. Baruteau AE, Perryd JC, Sanatanie S, Horie M, Walshg EP, Dubin AM. Evaluation and Management of Bradycardia in Neonates and Children. European Journal of Pediatrics 175:151-161. 2015
  18. Fukuyama M, Ohno S, Makiyama T, Horie M. Novel SCN10A variants associated with Brugada syndrome.Europace 18: 905-911. 2015
  19. Nakatsuma K, Shiomi H, Morimoto T, Ando K, Kadota K, Watanabe H, Taniguchi T, Yamamoto T, Furukawa Y, Nakagawa Y, Horie M, Kimura T; CREDO-Kyoto AMI investigators: Intravascular Ultrasound Guidance vs. Angiographic Guidance in Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction - Long-Term Clinical Outcomes From the CREDO-Kyoto AMI Registry. Circ J. 80: 477-484. 2015
  20. Miyamoto K, Aiba T, Kimura H, Hayashi H, Ohno S, Yasuoka C, Tanioka Y, Tsuchiya T, Yoshida Y, Hayashi H, Tsuboi I, Nakajima I, Ishibashi K, Okamura H, Noda T, Ishihara M, Anzai T, Yasuda S, Miyamoto Y, Kamakura S, Kusano K, Ogawa H, Horie M, Shimizu W: Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations. Heart Rhythm. 12: 596-603. 2015
  21. Harrell DT, Ashihara T, Ishikawa T, Tominaga I, Mazzanti A, Takahashi K, Oginosawa Y, Abe H, Maemura K, Sumitomo N, Uno K, Takano M, Priori SG, Makita N: Genotype-dependent differences in age of manifestation and arrhythmia complications in short QT syndrome. Int J Cardiol 190:393-402. 2015
  22. Zaid M, Fujiyoshi A, Miura K, Abbott RD, Okamura T, Takashima N, Torii S, Saito Y, Hisamatsu T, Miyagawa N, Ohkubo T, Kadota A, Sekikawa A, Maegawa H, Nakamura Y, Mitsunami K, Ueshima H, SESSA Research group: High-density lipoprotein particle concentration and subclinical atherosclerosis of the carotid arteries in Japanese men. Atherosclerosis. 239(2):444-50. 2015

このページの先頭へ

2014

  1. Hasegawa K, Ohno S, Ashihara T, Itoh H, Ding WG, Toyoda F, Makiyama T, Aoki H, Nakamura Y, Delisle BP, Matsuura H, Horie M. A novel KCNQ1 missense mutation identified in a patient with juvenile-onset atrial fibrillation causes constitutively open IKs channels. Heart Rhythm 11: 67-75, 2014.
  2. Hayashi H, Miyamoto A, Kawaguchi T, Naiki N, Xue J, Murakami Y, Horie M. P Pulmonale and the Development of Atrial Fibrillation. Circulation Journal 78: 329-337, 2014.
  3. Kato K, Makiyama T, Wu J, Ding WG, Kimura H, Naiki N, Ohno S, Itoh H, Nakanishi T, Matsuura H, Horie M. Cardiac Channelopathies Associated With Infantile Fatal Ventricular Arrhythmias, From The Cradle to The Bench. J Cardiovasc Electrophysiol 25: 66-73, 2014.
  4. Wang Q, Ohno S, Ding WG, Fukuyama M, Miyamoto A, Itoh H, Makiyama T, Wu J, Bai J, Hasegawa K, Shinohara T, Takahashi N, Shimizu A, Matsuura H, Horie M. Gain-of-Function KCNH2 Mutations in Patients with Brugada Syndrome. J Cardiovasc Electrophysiol. 25:522-530, 2014
  5. Ohno S, Omura M, Kawamura M, Kimura H, Itoh H, Makiyama T, Ushinohama H, Makita N, Horie M. Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non-compaction. Europace 16:1646-1654, 2014
  6. Kokunai Y, Nakata T, Furuta M, Sakata S, Kimura H, Aiba T, Yoshinaga M, Osaki Y, Nakamori M, Itoh H, Sato T, Kubota T, Kadota K, Shindo K, Mochizuki H, Shimizu W, Horie M, Okamura Y, Ohno K, Takahashi MP. A Kir3.4 mutation causes Andersen–Tawil syndrome by an inhibitory effect on Kir2.1. Neurology.82:1058-1064, 2104
  7. Sakata S, Kurata Y, Li P, Notsu T, Morikawa K, Miake J, Higaki K, Yamamoto Y, Yoshida A, Shirayoshi Y, Yamamoto K, Horie M, Ninomiya H, Kanzaki S, Hisatome I. Instability of KCNE1-D85N that causes long QT syndrome: stabilization by verapamil. PACE.37 :853-863, 2014
  8. Zhou J, Ding WG, Makiyama T, Miyamoto A, Matsumoto Y , Kimura H, Tarutani Y, Zhao J, Wu J, Zang WJ, Matsuura H, Horie M. A Novel HCN4 Mutation, G1097W, is associated with atrioventricular block. Circulation Journal. 78: 938-942, 2014
  9. Hayashi H, Kawaguchi T, Horie M. Effect of Flecainide on T-wave Alternans in Andersen-Tawil Syndrome. Annals of Noninvasive Electrocardiology. 19: 383-386, 2014
  10. Araki A, Katsuno M, Suzuki K, Banno H, Suga N, Hashizume A, Mano T, Hijikata Y, Nakatsuji H, Watanabe H, Makiyama T, Ohno S, Fukuyama M, Morimoto S, Horie M, Sobue G. Brugada syndrome in spinal and bulbar muscular atrophy (SBMA). Neurology 82: 1813-1821, 2014
  11. Hisamatsu T, Miura K, Ohkubo T, Yamamoto T, Fujiyoshi A, Miyagawa N, Kadota A, Takashima N, Okuda N, Yoshita K, Kita Y, Murakami Y, Nakamura Y, Okamura T, Horie M, Okayama A, Ueshima H, NIPPON DATA80 Research GroupHigh long-chain n-3 fatty acid intake attenuates the effect of high resting heart rate on cardiovascular mortality risk: A 24-year follow-up of Japanese general population. Journal of Cardiology. 64: 218-224, 2014
  12. Katsuumi G, Shimizu W, Watanabe H, Noda T, Nogami A, Ohkubo K, Makiyama T, Takehara N, Kawamura Y, Hosaka Y, Sato M, Fukae S, Chinushi M, Oda H, Okabe M, Kimura A, Maemura K, Watanabe I, Kamakura S, Horie M, Aizawa Y, Makita N, Minamino T. Efficacy of bepridil to prevent ventricular fibrillation in severe form of early repolarization syndrome. International Journal of Cardiology. 172: 519-522, 2014.
  13. Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Yamaji K, Ando K, Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Tamura T, Shirotani M, Miki S, Matsuda M, Takahashi M, Ishii K, Tanaka M, Aoyama T, Doi O, Hattori R, Kato M, Suwa S, Takizawa A, Takatsu Y, Shinoda E, Eizawa H, Takeda T, Lee JD, Inoko M, Ogawa H, Hamasaki S, Horie M, Nohara R, Kambara H, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T; on behalf of the CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Late Adverse Events After Implantation of Sirolimus-Eluting Stent and Bare-Metal Stent: Long-Term (5-7 Years) Follow-Up of the Coronary Revascularization Demonstrating Outcome Study-Kyoto Registry Cohort-2. Circ Cardiovasc Interv. 7: 168-179, 2014
  14. Wu J, Naiki N, Ding WG, Ohno S, Kato K, Zang WJ, Delisle BP, Matsuura H, Horie M. A molecular mechanism for adrenergic-induced long QT Syndrome. J Am Coll Cardiol. 63: 819-827, 2014
  15. Yoshinaga M, Kucho Y, Sarantuya J, Ninomiya Y, Horigome H, Ushinohama H, Shimizu W, Horie M. Genetic characteristics of children and adolescents with long QT syndrome diagnosed by school-based electrocardiographic screening programs. Circulation Arrhythmia and Electrophysiol. 7: 107-112, 2014.
  16. Bartos DC, Giudicessi JR, Tester DJ, Ackerman MJ, Ohno S, Horie M, Gollob MH, Burgess DE, Delisle BP. A KCNQ1 Mutation Contributes to the Concealed Type 1 Long QT Phenotype by Limiting the Kv7.1 Channel Conformational Changes Associated with PKA Phosphorylation. Heart Rhythm 11: 459-468, 2014.
  17. Fukuyama M, Ohno S, Wang Q, Shirayama T, Itoh H, Horie M. Nonsense-mediated mRNA decay due to a CACNA1C splicing mutation in a patient with Brugada syndrome. Heart Rhythm 11:629-634, 2014.
  18. Fukuyama M, Wang Q, Kato K, Ohno S, Ding WG, Toyoda F, Itoh H, Kimura H, Makiyama T, Ito M, Matsuura H, Horie M. Long QT syndrome Type8: novel CACNA1C mutations causing QT prolongation and variant phenotypes. Europace 16: 1828-1837, 2014.
  19. Abe Y, Sumitomo N, Okuma H, Nakamura T, Fukuhara J, Ichikawa R, Matsumura M, Miyashita M, Kamiyama H, Ayusawa M, Watanabe M, Joo K, Makita N, Horie M. Successful control of life-threatening polymorphic ventricular tachycardia by radiofrequency catheter ablation in an infant. Heart Vessels 29:422-426, 2014.
  20. Hasegawa K, Ohno S, Itoh H, Makiyama T, Aiba T, Nakano Y, Shimizu W, Matsuura H, Horie M. A rare KCNE1 polymorphism, D85N, as a genetic modifier of long QT syndrome. Journal of Arrhythmia 30: 161-166, 2014
  21. Nakatsuma k, Shiomi H, Watanabe H, Morimoto T, Taniguchi T, Toyota T, Furukawa Y, Nakagawa Y, Horie M, Kimura T, on behalf of the CREDO-Kyoto AMI investigators.Comparison of Long-term Mortality After Acute Myocardial Infarction Treated by Percutaneous Coronary Intervention in Patients Living Alone versus Not Living Alone at the Time of Hospitalizatio. Am J Cardiol. 114: 522-527, 2014.
  22. Goto K, Nakai K, Shizuta S, Morimoto T, Shiomi H, Natsuaki M, Yahata M, Ota C, Ono K, Makiyama T, Nakagawa Y, Furukawa Y, Kadota K, Takatsu Y, Tamura T, Takizawa A, Inada T, Doi O, Nohara R, Matsuda M, Takeda T, Kato M, Shirotani M, Eizawa H, Ishii K, Lee JD, Takahashi M, Horie M, Takahashi M, Miki S, Aoyama T, Suwa S, Hamasaki S, Ogawa H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T, CREDO-Kyoto Registry Cohort-2 Investigators. Anticoagulant and Antiplatelet Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention American Journal of Cardiology 114: 70-78, 2014.
  23. Fujii K, Ozeki Y, Okayasu H, Takano Y, Shinozaki T, Hori H, Orui M, Horie M, Kunugi H, Shimoda K. QT Is Longer in Drug-Free Patients with Schizophrenia Compared with Age-Matched Healthy Subjects. PLoS One 9: e98555. , 2014
  24. Watanabe E, Tanabe T, Osaka M, Chishaki A, Takase B, Niwano S, Watanabe I, Sugi K, Katoh T, Takayanagi K, Mawatari K, Horie M, Okumura K, Inoue H, Atarashi H, Yamaguchi I, Nagasawa S, Moroe K, Kodama I, Sugimoto T, Aizawa Y. Sudden cardiac arrest recorded during Holter monitoring: Prevalence, antecedent electrical events, and outcomes. Heart Rhythm 11:1418-1425, 2014
  25. Hisamatsu T, Fujiyoshi A, Miura K, Ohkubo T, Kadota A, Kadowaki S, Kadowaki T, Yamamoto T, Miyagawa N, Zaid M, Torii S, Takashima N, Murakami Y, Okamura T, Horie M, Ueshima H, for the SESSA Research Group. Lipoprotein particle profiles compared with standard lipids in association with coronary artery calcification in the general Japanese population. Atherosclerosis. 236(2): 237-243, 2014
  26. Nakae I, Hayashi H, Matsumoto T, Mitsunami K, Horie M. Clinical usefulness of a novel program "Heart Function View" for evaluating cardiac function from gated myocardial perfusion SPECT. Ann Nucl Med. 28: 812-823, 2014
  27. Furukawa S, Morita S, Okunaga H, Wingenfeld L, Takaya A, Nakagawa T, Sakaguchi I, Yamamoto Y, Ashihara T, Horie M, Nishi K, Hitosugi M. An autopsic examination case of diagnosed Brugada syndrome. American Journal of Industrail Medicine. 2: 79-82, 2014
  28. Kaneko Y, Horie M, Niwano S, Kusano K, Takatsuki S, Kurita T, Mitsuhashi T, Nakajima T, Irie T, Hasegawa K, Noda T, Kamakura S, Aizawa Y, Yasuoka R, Torigoe K, Suzuki H, Ohe T, Shimizu A, Fukuda K, Kurabayashi M, Aizawa Y. Electrical Storm in Patients with Brugada syndrome is Associated with Early Repolarization. Circulation-Arrhythmia and Electrophysiology 7:1122-1128, 2014
  29. Aizawa Y, Sato M, Ohno S, Horie M, Takatsuki S, Fukuda K, Chinushi M, Usui T, Aonuma K, Hosaka Y, Haissaguerre M, Aizawa Y. Circadian Pattern of Fibrillatory Events in non-Brugada-Type Idiopathic Ventricular Fibrillation with a Focus on J waves. Heart Rhythm11: 2261-2266, 2014
  30. Taniguchi T, Shiomi H, Toyota T, Morimoto T, Akao M, Nakatsuma K, Ono K, Makiyama T, Shizuta S, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Horie M, Kimura T. Effect of Preinfarction Angina Pectoris on Long-term Survival in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention. Am J Cardiol. 114: 1179-1186, 2014
  31. Shiomi H, Morimoto T, Makiyama T, Ono K, Furukawa Y, Nakagawa Y, Kadota K, Onodera T, Takatsu Y, Mitsudo K, Kita T, Sakata R, Okabayashi H, Hanyu M, Komiya T, Yamazaki F, Nishiwaki N, Kimura T; CREDO-Kyoto Investigators. Evolution in practice patterns and long-term outcomes of coronary revascularization from bare-metal stent era to drug-eluting stent era in Japan. Am J Cardiol. 113: 1652-1659, 2014
  32. Wijeyeratne YD, Muggenthaler M, Batchvarov V, Tanck M, Schott JJ, Kyndt F, Probst V, Shimizu W, Borggrefe M, McKeown P, Papadakis M, Veltmann C, Horie M, Crotti L, Schwartz P, Sharma S, Makita N, Roden D, Behr ER. 16Ethnicity and phenotype in the SCN5A E1784K mutation. Europace. 16, (suppl_3): iii7. 2014
  33. Mizusawa Y, Horie M, Wilde AA. Genetic and Clinical Advances in Congenital Long QT Syndrome. Circ J. 78: 2827-2833, 2014
  34. Tsumoto K, Ashihara T, Haraguchi R, Nakazawa K, Kurachi Y. Ischemia-related subcellular redistribution of sodium channels enhances the proarrhythmic effect of class i antiarrhythmic drugs: A simulation study. PLoS ONE 9: e109271, 2014
  35. Konishi S, Minaguchi H, Masuda M, Ashihara T, Okuyama Y, Ohtani T, Sakata Y: Self-terminated long-lasting ventricular fibrillation: What is the mechanism? J Cardiol Cases 10:136-139. 2014

このページの先頭へ

症例報告

このページの先頭へ

2013

  1. Villafane J, Atallah J, Gollob MH, Maury P, Wolpert C, Gebauer R, Watanabe H, Horie M, Anttonen O, Kannankeril P, Faulknier B, Bleiz J, Makiyama T, Hamilton R, Young M-L. Long Term Follow-up of a Pediatric Cohort with Short QT Syndrome. J Am Coll Cardiol. 61: 1183-1191, 2013.
  2. Wu J, Ding WG, Zhao J, Zang WJ, Matsuura H, Horie M. Irbesartan-mediated AT1 receptor blockade attenuates hyposmostic-induced enhancement of IKs current and prevents shortening of action potential duration in atrial myocytes. Journal of the Renin-Angiotensin-Aldosterone System. 0: 1-7, 2013
  3. Nakano Y, Chayama K, Ochi H, Toshisige M, Hayashida Y, Miki D, Hayes C. N, Suzuki H, TokuyamaT, Oda N, Suenari K, Uchimura-MakitaY, KajiharaK, Sairaku A, Motoda C, Fujiwara M, WatanabeY, YoshidaY, Ohkubo K, Watanabe I, Nogami A, Hasegawa K, Watanabe H, Endo N, Aiba T, Shimizu W, Ono S, Horie M, Arihiro K, Tashiro S, Makita N, Kihara Y. A nonsynonymous polymorphism in Semaphorin 3A as a risk factor for human unexplained cardiac arrest with documented ventricular fibrillation. PLOS Genetics 9: e1003364, 2013.
  4. Wang Q, Ohno S, Kato K, Fukuyama M, Makiyama T, Kimura H, Naiki N, Kawamura M, Hayashi H, Horie M. Genetic Screening of KCNJ8 in Japanese Patients with J-wave Syndromes or Idiopathic Ventricular Fibrillation. Journal of Arrhythmia 29: 261-264, 2013.
  5. Ohno S, Nagaoka I, Fukuyama M, Kimura H, Itoh H, Makiyama T, Shimizu A, Horie M. Age-dependent clinical and genetic characteristics in Japanese patients with arrhythmogenic right ventricular cardiomyopathy/ dysplasia. Circulation Journal 77: 1534-1542, 2013.
  6. Duchatelet S, Crotti L, Peat R, Denjoy I, Itoh H, Berthet M, Ohno S, Fressart V, Monti C, Crocamo C, Pedrazzini M, Dagradi F, Vicentini A, Klug D, Brink P, Goosen A, Heikki S, Toivonen L, Lahtinen A, Kontula K, Shimizu W, Horie M, George Jr. AL, Tregouet DA, Guicheney P, Schwartz PJ. Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long QT syndrome. Circulation Cardiovasc Genet 6: 354-361, 2013.
  7. Takagi M, Aonuma K, Sekiguchi Y, Yokoyama Y, Aihara N, Hiraoka M, FHRS. The prognostic value of early repolarization (J wave) and ST- segment morphology after J wave in Brugada syndrome: Multicenter study in Japan. Heart Rhythm 10: 533-539, 2013.
  8. Dochi K, Watanabe H, Kawamura M, Miyamoto A, Ozawa T, Nakazawa Y, Ashihara T, Ohno S, Hayashi H, Ito M, Sakazaki H, Kawata H, Ushinohama H, Kaszynski RH, Minamino T, Sumitomo N, Shimizu W, Horie M. Flecainide reduces ventricular arrhythmias via different actions from β-blockers in catecholaminergic polymorphic ventricular tachycardia. Journal of Arrhythmia 29: 255-260, 2013.
  9. Fukuyama M, Ohno S, Wang Q, Kimura H, Makiyama T, Itoh H, Ito M, Horie M. L-type calcium channel mutations in Japanese patients with inherited arrhythmias. Circulation Journal 77: 1799-1806, 2013.
  10. Kawamura M, Ohno S, Naiki N, Nagaoka I, Dohchi K, Wang Q, Hasegawa K, Kimura H, Miyamoto A, Mizusawa Y, Itoh H, Makiyama T, Sumitomo N, Ushinohama H, Oyama K, Murakoshi N, Aonuma K, Horigome H, Honda T, Yoshinaga M, Ito M, Horie M. Genetic background of catecholaminergic polymorphic ventricular tachycardia in Japan. Circulation Journal 77: 1705-1713, 2013.
  11. Hisamatsu T, Ohkubo T, Miura K, Yamamoto T, Fujiyoshi A, Miyagawa N, Kadota A, Takashima N, Nagasawa SY, Kita Y, Murakami Y, Okayama A, Horie M, Okamura T, Ueshima H; NIPPON DATA90 Research Group. The Association between J-point elevation and death from coronary heart disease: a 15-year follow-up of the NIPPON DATA90. Circulation Journal 77: 1260-1266, 2013.
  12. Aizawa Y, Chinushi M, Hasegawa K, Naiki N, Horie M, Kaneko Y, Kurabayashi M, Ito S, Imaizumi T, Aizawa Y, Takatsuki S, Joo K, Sato M, Ebe K, Hosaka Y, Haissaguerre M, Fukuda K. Electrical storm in idiopathic ventricular fibrillation is associated with early repolarization. J Am Coll Cardiol. 62: 1015-1019, 2013.
  13. Hisamatsu T, Miura K, Ohkubo T, Yamamoto T, Fujiyoshi A, Miyagawa N, Kadota A, Takashima N, Okuda N, Matsumura Y, Yoshita K, Kita Y, Murakami Y, Okamura T, Horie M, Okayama A, Ueshima H for the NIPPON DATA80 Research Group. Interaction between dietary marine-derived n-3 fatty acids intake and J-point elevation on the risk of cardiac death: a 24-year follow-up of Japanese men. Heart 99: 1024-1029, 2013.
  14. Watanabe H, van der Werf C, Roses-Noguer F, Adler A, Sumitomo N, Veltmann C, Rosso R, Bhuiyan ZA, Bikker H, Kannankeril PJ, Horie M, Minamino T, Viskin S, Knollmann BC, Till J, Wilde AA. Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 10: 542-547, 2013.
  15. Horie M, Ohno S. Genetic basis of Brugada syndrome. Journal of Arrhythmia 29: 71–76, 2013.
  16. Tazaki J, Shiomi H, Morimoto T, Imai M, Yamaji K, Sakata R, Okabayashi H, Hanyu M, Shimamoto M, Nishiwaki N, Komiya T, Kimura T. Three-year outcome after percutaneous coronary intervention and coronary artery bypass grafting in patients with triple vessel coronary artery disease: observations from the CREDO-Kyoto PCI/CABG registry cohort-2. EuroIntervention 9:437-445, 2013.
  17. Morikami Y, Natsuaki M, Morimoto T, Ono K, Nakagawa Y, Furukawa Y, Sakata R, Aota M, Okada Y, Onoe M, Kawasuji M, Koshiji T, Nakajima H, Nishizawa J, Yamanaka K, Yamamoto H, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Impact of polyvascular disease on clinical outcomes in patients undergoing coronary revascularization: An observation from the CREDO-Kyoto Registry Cohort-2. Atherosclerosis 228: 426-431, 2013.
  18. Kamakura T, Makiyama T, Sasaki K, Yoshida Y, Wuriyanghai Y, Chen J, Hattori T, Ohno S, Kita T, Horie M, Yamanaka S, Kimura T. Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture. Circulation Journal. 77: 1307-1314, 2013.
  19. Nakae I, Hayashi H, Mitsunami K, Horie M. Clinical significance of lung iodine-123 metaiodobenzylguanidine uptake assessment in Parkinson's and heart diseases. Ann Nucl Med.27: 737–747, 2013.
  20. Bezzina CR, Barc J, Mizusawa Y, Remme CA, Gourraud JB, Simonet F, Verkerk AO, Schwartz PJ, Crotti L, Dagradi F, Guicheney P, Fressart V, Leenhardt A, Antzelevitch C, Bartkowiak S, Schulze-Bahr E, Zumhagen S, Behr ER, Bastiaenen R, Tfelt-Hansen J, Olesen MS, Kääb S, Beckmann BM, Weeke P, Watanabe H, Endo N, Minamino T, Horie M, Ohno S, Hasegawa K, Makita N, Nogami A, Shimizu W, Aiba T, Froguel P, Balkau B, Lantieri O, Torchio M, Wiese C, Weber D, Wolswinkel R, Coronel R, Boukens BJ, Bézieau S, Charpentier E, Chatel S, Despres A, Gros F, Kyndt F, Lecointe S, Lindenbaum P, Portero V, Violleau J, Gessler M, Tan HL, Roden DM, Christoffels VM, Marec HL, Wilde AA, Probst V, Schott JJ, Dina C, Redon R. Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nature Genetics 45: 1044-1049, 2013.
  21. Hayashi H, Murakami Y, Horie M. Pitfall of the meta-analysis regarding early repolarization pattern. J Am Coll Cardiol. 62(1): 86, 2013.
  22. Smith JL, Reloj AR, Nataraj PS, Bartos DC, Schroder EA, Moss AJ, Ohno S, Horie M, Anderson CL, January CT, Delisle BP. Pharmacological Correction of Long QT-linked Mutations in KCNH2 (hERG) Increases the Trafficking of Kv11.1 Channels Stored in the Transitional ER. American Journal of Physiology-Cell Physiology 305(9):C919-30, 2013.
  23. Ishikawa T, Takahashi N, Ohno S, Sakurada H, Nakamura K, On YK, Park JE, Makiyama T, Horie M, Arimura T, Makita N, Kimura A. Novel SCN3B Mutation Associated With Brugada Syndrome Affects Intracellular Trafficking and Function of Nav1.5. Circulation Journal 77(4): 959-967, 2013.
  24. Hisamatsu T, Ohkubo T, Miura K, Yamamoto T, Fujiyoshi A, Miyagawa A, Kadota A, Takashima N, Nagasawa S, Kita Y, Murakami Y, Okayama A, Horie M, Okamura T, Ueshima H. Is more aggressive prevention of coronary artery disease required for patients with early repolarization syndrome?--Reply. Circulation Journal 77(6): 1643, 2013.
  25. Kawaguchi T, Hayashi H, Naiki N, Sakai H, Yamamoto T, Fujita M, Horie M. Spontaneous coronary artery spasm accidentally detected by 320-row multi-detector computed tomography.Journal of Cardiology Cases 8(2):e85-e87,2013
  26. Nakae I, Hayashi H, Mitsunami K, Horie M. Clinical significance of lung iodine-123 metaiodobenzylguanidine uptake assessment in Parkinson’s and heart diseases. Ann Nucl Med 27(8): 737-47,2013.
  27. Barc J, Bezzina C, Mizusawa Y, Remme C, Gourraud J, Verkerk A, Schwartz P, Guicheney P, Antzelevitch C, Schulze-Bahr E, Behr E, Tfelt-Hanson J, Kaab S, Watanabe H, Horie M, Makita N, Shimizu W, Roden D, Christoffels V, Gessler M, Wilde A, Probst V, Schott J, Dina C, Redon R. Genome-wide association analysis identifies 3 common variants predisposing to brugada syndrome, a rare disease with high risk of sudden cardiac death. Heart Rhythm. 10(11): 1743-4, 2013.
  28. Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, Blom N, Brugada J, Chiang CE, Huikuri H, Kannankeril P, Krahn A, Leenhardt A, Moss A, Schwartz PJ, Shimizu W, Tomaselli G, Tracy C. HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes: Document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 10(12): 1932-63, 2013.
  29. Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, Blom N, Brugada J, Chiang CE, Huikuri H, Kannankeril P, Krahn A, Leenhardt A, Moss A, Schwartz PJ, Shimizu W, Tomaselli G, Tracy C; Document Reviewers, Ackerman M, Belhassen B, Estes NA 3rd, Fatkin D, Kalman J, Kaufman E, Kirchhof P, Schulze-Bahr E, Wolpert C, Vohra J, Refaat M, Etheridge SP, Campbell RM, Martin ET, Quek SC. Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace. 15(10): 1389-406, 2013.
  30. Hayashi H, Shibukawa T, Horie M. Restoration of aberrant conduction induced by premature ventricular contractions. Intern Med. 52(12):1425, 2013.
  31. Kadota A, Miura K, Okamura T, Fujiyoshi A, Ohkubo T, Kadowaki T, Takashima N, Hisamatsu T, Nakamura Y, Kasagi F, Maegawa H, Kashiwagi A, Ueshima H; SESSA Research Group; NIPPON DATA80/90 Research Group. Carotid intima-media thickness and plaque in apparently healthy Japanese individuals with an estimated 10-year absolute risk of CAD death according to the Japan Atherosclerosis Society (JAS) guidelines 2012: the Shiga Epidemiological Study of Subclinical Atherosclerosis (SESSA). J Atheroscler Thromb. 20(10): 755-66, 2013.
  32. Okamura T, Sekikawa A, Sawamura T, Kadowaki T, Barinas-Mitchell E, Mackey RH, Kadota A, Evans RW, Edmundowicz D, Higashiyama A, Nakamura Y, Abbott RD, Miura K, Fujiyoshi A, Fujita Y, Murakami Y, Miyamatsu N, Kakino A, Maegawa H, Murata K, Horie M, Mitsunami K, Kashiwagi A, Kuller LH, Ueshima H; ERA JUMP Study Group. LOX-1 ligands containing apolipoprotein B and carotid intima-media thickness in middle-aged community-dwelling US Caucasian and Japanese men. Atherosclerosis. 229(1):240-5, 2013
  33. Abe A, Fujino T, Fukunaga S, Yuzawa H, Sato H, Suzuki T, Kobayashi K, Okano Y, Nakamura K, Yusu S, Yoshino H, Ashihara T, Nakazawa K, Ikeda T. Prevalence and prognosis of patients with lone and paroxysmal atrial tachyarrhythmias showing Brugada-type electrocardiograms after class IC antiarrhythmic drug administration but no risk-stratifying factors. J Arrhythm 29:138-142, 2013
  34. Inada S, Ono T, Shibata N, Iwata M, Haraguchi R, Ashihara T, Mitsui K, Boyett MR, Dobrzynski H, Nakazawa K. Simulation study of complex action potential conduction in atrioventricular node. Conf Proc IEEE Eng Med Biol Soc 6850-6853, 2013

このページの先頭へ

症例報告

このページの先頭へ

2012

  1. Ashihara T, Haraguchi R, Nakazawa K, Namba T, Ikeda T, Nakazawa Y, Ozawa T, Ito M, Horie M, Trayanova NA: The role of fibroblasts in complex fractionated electrograms during persistent/permanent atrial fibrillation implications for electrogram-based catheter ablation. Circ Res. 110(2): 275-284, 2012.
  2. Ijiri T, Ashihara T, Umetani N, Igarashi T, Haraguchi R, Yokota H, Nakazawa K: A kinematic approach for efficient and robust simulation of cardiac beating motion. PLoS ONE. 7(5): e36706, 2012.
  3. Yamazaki M, Honjo H, Ashihara T, Harada M, Sakuma I, Nakazawa K, Trayanova N, Horie M, Kalifa J, Jalife J, Kamiya K, Kodama I: Regional cooling facilitates termination of spiral-wave reentry through unpinning of rotors in rabbit hearts. Heart Rhythm. 9(1): 107-114, 2012.
  4. Kato S, Honjo H, Takemoto Y, Takanari H, Suzuki T, Okuno Y, Opthof T, Sakuma I, Inada S, Nakazawa K, Ashihara T, Kodama I, Kamiya K: Pharmacological blockade of IKs destabilizes spiral-wave reentry under β-adrenergic stimulation in favor of its early termination. J Pharmacol Sci. 119(1): 52-63, 2012.
  5. Miyamoto A, Hayashi H, Yoshino T, Kawaguchi T, Taniguchi A, Ito H, Sugimoto Y, Ito M, Makiyama T, Xue JQ, Murakami Y, Horie M: Clinical and electrocardiographic characteristics of patients with short QT interval in a large hospital-based population. Heart Rhythm. 9(1): 66-74, 2012.
  6. Shizuta S, Ando K, Nobuyoshi M, Ikeda T, Yoshino H, Hiramatsu S, Kazatani Y, Yamashiro K, Okajima K, Kajiya T, Kobayashi Y, Kato T, Fujii S, Mitsudo K, Inoue K, Ito H, Haruna Y, Doi T, Nishio Y, Ozasa N, Nishiyama K, Kita T, Morimoto T, Kimura T, for the PREVENT-SCD Investigators: Prognostic utility of T-wave alternans in a real-world population of patients with left ventricular dysfunction: the PREVENT-SCD study. Clin Res Cardiol. 101(2): 89-99, 2012.
  7. Hattori T, Makiyama T, Akao M, Ehara E, Ohno S, Iguchi M, Nishio Y, Sasaki K, Itoh H, Yokode M, Kita T, Horie M, Kimura T: A novel gain-of-function KCNJ2 mutation associated with short QT syndrome impairs inward rectification of Kir2.1 currents. Cardiovasc Res. 93(4): 666-673, 2012.
  8. Makita N, Seki A, Sumitomo N, Fukuhara S, Watanabe H, Shimizu W, Bezzina CR., Hasdemir C, Mugishima H, Makiyama T, Baruteau A, Baron E, Horie M, Hagiwara N, Wilde AAM, Probst V, Marec HL, Delmar M, Roden DM, Mochizuki N, Schott JJ: A Connexin 40 mutation associated with a malignant variant of familial progressive heart block type-1. Circ Arrhythm Electrophysiol. 5(1): 163-172, 2012.
  9. Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Tomohisa Tada T, Tazaki J, Shiomi H, Kato Y, Hayano M, Abe M, Ehara N, Mizoguchi T, Mitsuoka H, Inada T, Araki M, Kaburagi S, Taniguchi R, Eizawa H, Nakano A, Tei C, Horie M, Ogawa H, Tamura T, Shirotani M, Takahashi M, Ishii I, Tatami R, Suwa T, Takizawa A, Takahashi M, Takeda T, Nohara R, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T, on behalf of the CREDO-Kyoto PCI/CABG registry cohort-2 investigators: Comparison of three-year clinical outcomes after transradial versus transfemoral percutaneous coronary intervention. Am J Cardiol. 110(7): 924-932, 2012.
  10. Wu J, Ding WG, Matsuura H, Horie M: Regulatory mechanisms underlying the modulation of GIRK1/GIRK4 heteromeric channels by P2Y receptors. Pflugers Arch. 463(4): 625-633, 2012.
  11. Aizawa Y, Sato A, Watanabe H, Chinushi M, Furushima H, Horie M, Kaneko Y, Imaizumi T, Okubo K, Watanabe I, Shinozaki T, Aizawa Y, Fukuda K, Joo K, Haissaguerre M: Dynamicity of the J wave in idiopathic ventricular fibrillation with a special reference to pause-dependent augmentation of the J wave. J Am Coll Cardiol. 59(22): 1948-1953, 2012.
  12. Okayasu H, Ozeki Y, Fujii K, Takano Y, Saeki Y, Hori H, Horie M, Higuchi T, Kunugi H, Shimoda K: Pharmachotherapeutic determinants for QTc interval prolongation in Japanese patients with mood disorder. Pharmacopsychiatry. 45(7): 279-283, 2012.
  13. Kinoshita T, Asai T, Suzuki T, Matsubayashi K, Horie M: Time course and prognostic implications of QT interval in patients with coronary artery disease undergoing coronary bypass surgery. J Cardiovasc Electrophysiol. 23(6): 645-649, 2012.
  14. Watanabe H, Nogami A, Ohkubo K, Kawata H, Hayashi Y, Ishikawa T, Makiyama T, Nagao S, Yagihara N, Takehara N, Kawamura Y, Sato A, Okamura K, Hosaka Y, Sato M, Fukae S, Chinushi M, Oda H, Okabe M, Kimura A, Maemura K, Watanabe I, Kamakura S, Horie M, Aizawa Y, Shimizu W, Makita N: Response to letter regarding article, "Electrocardiographic characteristics and SCN5A mutations in idiopathic ventricular fibrillation associated with early repolarization". Circ Arrhythm Electrophysiol. 5(2): e60-e61, 2012.
  15. Kimura H, Zhou J, Kawamura M, Itoh H, Mizusawa Y, Ding WG, Wu J, Ohno S, Makiyama T, Miyamoto A, Naiki N, Wang Q, Xie Y, Suzuki T, Tateno S, Nakamura Y, Zang WJ, Ito M, Matsuura H, Horie M: Phenotype variability in patients carrying KCNJ2 mutations. Circ Cardiovasc Genet. 5(3): 344-353, 2012.
  16. Shiomi H, Morimoto T, Hayano M, Furukawa Y, Nakagawa Y, Tazaki J, Imai M, Yamaji K, Tada T, Natsuaki M, Saijo S, Funakoshi S, Nagao K, Hanazawa K, Ehara N, Kadota K, Iwabuchi M, Shizuta S, Abe M, Sakata R, Okabayashi H, Hanyu M, Yamazaki F, Shimamoto M, Nishiwaki N, Imoto Y, Komiya T, Horie M, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T, CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators: Comparison of long-term outcome after percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease (from the CREDO-Kyoto PCI/CABG Registry Cohort-2). Am J Cardiol. 110(7): 924-932, 2012.
  17. Watanabe H, Nogami A, Ohkubo K, Kawata H, Hayashi Y, Ishikawa T, Makiyama T, Nagao S, Yagihara N, Takehara N, Kawamura Y, Sato A, Okamura K, Hosaka Y, Sato M, Fukae S, Chinushi M, Oda H, Okabe M, Kimura A, Maemura K, Watanabe I, Kamakura S, Horie M, Aizawa Y, Shimizu W, Makita N: Clinical characteristics and risk of arrhythmia recurrences in patients with idiopathic ventricular fibrillation associated with early repolarization. Int J Cardiol. 159(3): 238-240, 2012.
  18. Egashira T, Yuasa S, Suzuki T, Aizawa Y, Yamakawa H, Matsuhashi T, Ohno Y, Tohyama S, Okata S, Seki T, Kuroda Y, Yae K, Hashimoto H, Tanaka T, Hattori F, Sato T, Miyoshi S, Takatsuki S, Murata M, Kurokawa J, Furukawa T, Makita N, Aiba T, Shimizu W, Horie M, Kamiya K, Kodama I, Ogawa S, Fukuda K: Disease characterization using LQTS-specific induced pluripotent stem cells. Cardiovasc Res. 95(4): 419-429, 2012.
  19. Tokushige A, Shiomi H, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Ehara N, Inada T, Kaburagi S, Hamasaki S, Tei C, Nakashima H, Ogawa H, Tatami R, Suwa S, Takizawa A, Nohara R, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T, CREDO-Kyoto PCI/CABG registry cohort-2 investigators: Incidence and outcome of surgical procedures after coronary bare-metal and drug-eluting stent implantation: a report from the CREDO-Kyoto PCI/CABG registry cohort-2. Circ Cardiovasc Interv. 5(2): 237-246, 2012.
  20. Tada T, Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Byrne RA, Kastrati A, Kadota K, Iwabuchi M, Shizuta S, Tazaki J, Shiomi H, Abe M, Ehara N, Mizoguchi T, Mitsuoka H, Inada T, Araki M, Kaburagi S, Taniguchi R, Eizawa H, Nakano A, Suwa S, Takizawa A, Nohara R, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T, on behalf of the CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators: Duration of dual antiplatelet therapy and long-term clinical outcome after coronary drug-eluting stent implantation: landmark analyses from the CREDO-Kyoto PCI/CABG Registry Cohort-2. Circ Cardiovasc Interv. 5(3): 381-391, 2012.
  21. Shiomi H, Nakagawa Y, Morimoto T, Furukawa Y, Nakano A, Shirai S, Taniguchi R, Yamaji K, Nagao K, Suyama T, Mitsuoka H, Araki M, Takashima H, Mizoguchi T, Eisawa H, Sugiyama S, Kimura T, CREDO-Kyoto AMI investigators: Association of onset to balloon and door to balloon time with long term clinical outcome in patients with ST elevation acute myocardial infarction having primary percutaneous coronary intervention: observational study. BMJ. 344: e3257, 2012.
  22. Takigawa M, Kawamura M, Noda T, Yamada Y, Miyamoto K, Okamura H, Satomi K, Aiba T, Kamakura S, Sakaguchi T, Mizusawa Y, Itoh H, Horie M, Shimizu W: Seasonal and circadian distributions of cardiac events in genotyped patients with congenital long QT syndrome. Circ J. 76(9): 2112-2118, 2012.
  23. Nakajima T, Wu J, Kaneko Y, Ashihara T, Ohno S, Irie T, Ding WG, Matsuura H, Kurabayashi M, Horie M: KCNE3 T4A as a genetic background of Brugada-pattern electrocardiogram. Circ J. 76(12): 2763-2772, 2012.
  24. Kawaguchi T, Hayashi H, Miyamoto A, Yoshino T, Taniguchi A, Naiki N, Sugimoto Y, Ito M, Xue J-Q, Murakami Y, Horie M: Prognostic implications of progressive cardiac conduction disease. Circ J. 77(1):60-7, 2012.
  25. Momomura S, Tsutsui H, Sugawara Y, Ito M, Mitsuhashi T, Fukamizu S, Noro M, Matsumoto N, Tejima T, Sugi K: Clinical efficacy of cardiac resynchronization therapy with an implantable defibrillator in a Japanese population: results of the MIRACLE-ICD outcome measured in Japanese indication (MOMIJI) study. Circ J. 76(8): 1911-1919, 2012.
  26. Isono T, Matsumoto T, Wada A, Suzaki M, Chano T. A global transcriptome analysis of a dog model of congestive heart failure with the human genome as a reference. J Card Fail. 18(11):872-8, 2012.
  27. Burgess DE, Bartos DC, Reloj AR, Campbell KS, Johnson JN, Tester DJ, Ackerman MJ, Fressart V, Denjoy I, Guicheney P, Moss AJ, Ohno S, Horie M, Delisle BP. High-risk long QT syndrome mutations in the Kv7.1 (KCNQ1) pore disrupt the molecular basis for rapid K(+) permeation. Biochemistry 51(45):9076-85, 2012.

このページの先頭へ

症例報告

このページの先頭へ

2011

  1. Haraguchi R, Ashihara T, Namba T, Tsumoto K, Murakami S, Kurachi Y, Ikeda T, Nakazawa K: Transmural dispersion of repolarization determines scroll wave behavior during ventricular tachyarrhythmias. Circ J. 75: 80-88, 2011.
  2. Trayanova N, Constantino J, Ashihara T, Plank G: Modeling defibrillation of the heart: Approaches and insights. IEEE Rev Biomed Eng. 4: 89-102, 2011.
  3. Takanari H, Honjo H, Takemoto Y, Suzuki T, Kato S, Harada M, Okuno Y, Ashihara T, Opthof T, Sakuma I, Kamiya K, Kodama I: Bepridil facilitates early termination of spiral-wave reentry in two-dimensional cardiac muscle through an increase of intercellular electrical coupling. J Pharmacol Sci.115: 15-26, 2011.
  4. Matsumoto T, Eguchi Y, Oda H, Yamane T, Tarutani Y, Ozawa T, Hayashi H, Nakae I, Horie M, Urade Y: Lipocalin-type prostaglandin D synthase is associated with coronary vasospasm and vasomotor reactivity in response to acetylcholine. Circ J. 75: 897-904, 2011.
  5. Li P, Ninomiya H, KurataY, Kato M, Miake J, Yamamoto Y, Igawa O, Nakai A, Higaki K, Toyoda F, Wu J, Horie M, Shirayoshi Y, Hiraoka M, Hisatome I: Reciprocal control of hERG stability by Hsp70 and Hsc70 with implication for restoration of LQT2 mutant stability. Circ Res. 108: 458-468, 2011.
  6. Miyamoto A, Hayashi H, Makiyama T, Yoshino T, Mizusawa Y, Sugimoto Y, Ito M, Xue JQ, Murakami Y, Horie M: Risk determinants in individuals with a spontaneous type 1 Brugada ECG. Circ J. 75: 844-851, 2011.
  7. Matsumoto T, Horie M: Angiotensin-converting enzyme inhibition and fibrinolytic balance. Hypertens Res. 34: 448-449, 2011.
  8. Nishiyama K, Tsutamoto T, Yamaji M, Kawahara C, Fujii M, Yamamoto T, Horie M: Biological variation of brain natriuretic peptide and cardiac events in stable outpatients with nonischemic chronic heart failure. Circ J. 75: 341-347, 2011.
  9. Ohno S, Zankov DP, Ding WG, Itoh H, Makiyama T, Doi T, Shizuta S, Hattori T, Miyamoto A, Naiki N, Hancox JC, Matsuura H, Horie M: KCNE5 (KCNE1L) variants are novel modulators of brugada syndrome and idiopathic ventricular fibrillation. Circ Arrhythm Electrophysiol. 4: 352-361, 2011.
  10. Doi T, Makiyama T, Morimoto T, Haruna Y, Tsuji K, Ohno S, Akao M, Takahashi Y, Kimura T, Horie M: A novel KCNJ2 nonsense mutation, S369X, impedes trafficking and causes a limited form of andersen-tawil syndrome. Circ Cardiovasc Genet. 4: 253-260, 2011.
  11. Shimizu W, Horie M: Phenotypical manifestations of mutations in genes encoding subunits ofcardiac potassium channels. Circ Res. 109: 97-109, 2011.
  12. Takagi Y, Yasuda S, Tsunoda R, Ogata Y, Seki A, Sumiyoshi T, Matsui M, Goto T, Tanabe Y, Sueda S, Sato T, Ogawa S, Kubo N, Momomura S, Ogawa H, Shimokawa H; Japanese Coronary Spasm Association: Clinical characteristics and long-term prognosis of vasospastic angina patients who survived out-of-hospital cardiac arrest: multicenter registry study of the Japanese Coronary Spasm Association. Circ Arrhythm Electrophysiol. 4: 295-302, 2011.
  13. Kawahara C, Tsutamoto T, Nishiyama K, Yamaji M, Sakai H, Fujii M, Yamamoto T, Horie M: Prognostic role of high-sensitivity cardiac troponin T in patients with nonischemic dilated cardiomyopathy. Circ J 75: 656-661, 2011.
  14. Tsumoto K, Ashihara T, Haraguchi R, Nakazawa K, Kurachi Y: Roles of subcellular Na+ channel distributions in the mechanism of cardiac conduction. Biophys J. 100: 554-563, 2011.
  15. Nishiyama K, Tsutamoto T, Kawahara C, Yamaji M, Sakai H, Yamamoto T, Fujii M, Horie M: Relationship between biological variation in B-type natriuretic peptide and plasma renin concentration in stable outpatients with dilated cardiomyopathy. Circ J. 75: 1897-1904, 2011.
  16. Tsuji K, Akao M, Ishii TM, Ashihara T, Makiyama T, Ohno S, Toyoda F, Nishio Y, Sakaguchi T, Matsuura H, Horie M: Identification and functional characterization of KCNQ1 mutations around the exon7-intron7 junction affecting the splicing process. BBA - Molecular Basis of Disease. 1812(11): 1452-1459, 2011.
  17. Yoshino T, Nakae I, Matsumoto T, Mitsunami K, Horie M: Association between brachial-ankle pulse wave velocity and endothelium-dependent and -independent coronary vasomotor function. Clin Exp Pharmacol Physiol. 38: 34-41, 2011.
  18. Watanabe H, Nogami A, Ohkubo K, Kawata H, Hayashi Y, Ishikawa T, Makiyama T, Nagao S, Yagihara N, Takehara N, Kawamura Y, Sato A, Okamura K, Hosaka Y, Sato M, Fukae S, Chinushi M, Oda H, Okabe M, Kimura A, Maemura K, Watanabe I, Kamakura S, Horie M, Aizawa Y, Shimizu W, Makita N: Electrocardiographic characteristics and SCN5A mutations in idiopathic ventricular fibrillation associated with early repolarization. Circ Arrhythm Electrophysiol. 4: 874-881, 2011.
  19. Kawahara C, Tsutamoto T, Sakai H, Nishiyama K, Yamaji M, Fujii M, Yamamoto T, Horie M: Prognostic value of serial measurements of highly sensitive cardiac troponin I in stable outpatients with nonischemic chronic heart failure. Am Heart J. 162: 639-645, 2011.
  20. Funakoshi S, Furukawa Y, Ehara N, Morimoto T, Kaji S, Yamamuro A, Kinoshita M, Kitai T, Kim K, Tani T, Kobori A, Nasu M, Okada Y, Kita T, Kimura T; CREDO-Kyoto Investigators: Clinical characteristics and outcomes of Japanese women undergoing coronary revascularization therapy. Circ J.75: 1358-1367, 2011.
  21. Tsutamoto T, Sakai H, Ibe K, Yamaji M, Kawahara C, Nakae I, Fujii M, Yamamoto T, Horie M: Effect of atorvastatin vs. rosuvastatin on cardiac sympathetic nerve activity in non-diabetic patients with dilated cardiomyopathy. Circ J. 75: 2160-2166, 2011.
  22. Kimura H, Mizusawa Y, Itoh H, Miyamoto A, Kawamura M, Kawaguchi T, Naiki N, Oka Y, Ohno S, Makiyama T, Ito M, Horie M: Carvedilol, a non-selective β-with α1-blocker is effective in long QT syndrome type 2. J Arrhythm. 27: 324-331, 2011.
  23. Kimura T, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Tazaki J, Kato Y, Hayano M, Abe M, Tamura T, Shirotani M, Miki S, Matsuda M, Takahashi M, Ishii K, Tanaka M, Aoyama T, Doi O, Hattori R, Tatami R, Suwa S, Takizawa A, Takatsu Y, Takahashi M, Kato H, Takeda T, Lee J-D, Nohara R, Tei C, Horie M, Kambara H, Fujiwara H, Mitsudo Km Nobuyoshi M, Kita T: Association of the use of proton pump inhibitors with adverse cardiovascular and bleeding outcomes after percutaneous coronary intervention in the Japanese real world clinical practice. Cardiovasc Interv Ther. 26: 222-233, 2011.
  24. Kimura T, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Tamura T, Shirotani M, Miki S, Matsuda M, Takahashi M, Ishii K, Tanaka M, Aoyama T, Doi O, Hattori R, Tatami R, Suwa S, Takizawa A, Takatsu Y, Takahashi M, Kato H, Takeda T, Lee JD, Nohara R, Ogawa H, Tei C, Horie M, Kambara H, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T: Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinicalpractice in Japan. Cardiovasc Interv Ther. 26: 234-245, 2011.
  25. Miyamoto A, Hayashi H, Yoshino T, Kawaguchi T, Taniguchi A, Itoh H, Sugimoto Y, Itoh M, Makiyama T, Xue JQ, Murakami Y, Horie M: Clinical and electrocardiographic characteristics of patients with short QT interval in a large hospital-based population. Heart Rhythm. 9: 66-74, 2011.
  26. Kimura T, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Tamura T, Shirotani M, Miki S, Matsuda M, Takahashi M, Ishii K, Tanaka M, Aoyama T, Doi O, Hattori R, Tatami R, Suwa S, Takizawa A, Takatsu Y, Takahashi M, Kato H, Takeda T, Lee JD, Nohara R, Tei C, Horie M, Kambara H, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, on behalf of the CREDO-Kyoto PCI/CABG registry cohort-2 investigators: Association of the use of proton pump inhibitors with adverse cardiovascular and bleeding outcomes after percutaneous coronary intervention in the Japanese real world clinical practice. Cardiovasc Interv Ther. 26, 222-233, 2011.
  27. Zhu B, Iwata M, Haraguchi R, Ashihara T, Umetani N, Igarashi T, Nakazawa K: Sketch-based dynamic illustration of fluid systems. ACM Transactions on Graphics 30:134 2011

このページの先頭へ

症例報告

このページの先頭へ

2010

  1. Ozeki Y, Fujii K, Kuromoto N, Yamada N, Okawa M, Aoki T, Takahashi J, Narita M, Ishida N, Saito O, Horie M, Kunugi H: QTc prolongation and antipsychotic medication in 1017 patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 34(2): 401-405, 2010.
  2. Tsutamoto T, Kawahara C, Nishiyama K, Yamaji M, Fujii M, Yamamoto T, Horie M: Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure. Am Heart J. 15(1): 63-67, 2010.
  3. Tsutamoto T, Nishiyama K, Yamaji M, Kawahara C, Fujii M, Yamamoto T, Horie M: Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension. Hypertens Res. 33(2): 118-122, 2010.
  4. Wu J, Shimizu W, Ding W-G, Ohno S, Toyada F, Itoh H, Zang W-J, Miyamoto Y, Kamakura S, Matsuura H, Nademanee J, Brugada J, Brugada P, Brugada R, Vatta M, Towbin JA, Antzelevitch C, Horie M: KCNE2 modulation of Kv4.3 current and its potential role in fatal rhythm disorders. Heart Rhythm. 7(2): 199-205, 2010.
  5. Horigome H, Nagashima M, Sumitomo N, Yoshinaga M, Ushinohama H, Iwamoto M, Shiono J, Ichihashi K, Hasegawa S, Yoshikawa T, Matsunaga T, Goto H, Waki K, Arima M, Takasugi H, Tanaka Y, Miura M, Ogawa K, Suzuki H, Yamagishi H, Ikoma M, Suda K, Takagi J, Sato J, Shimizu H, Saiki H, Hoshiai M, Ichida F, Takeda S, Takigiku K, Inamura N, Kajino H, Murakami T, Shimizu W, Horie M: Clinical characteristics and genetic background of congenital long QT syndrome diagnosed in fetal, neonatal and infantile life. A nation-wide questionnaire survey in Japan. Circ Arrhythm Electrophysiol. 3(1): 10-17, 2010.
  6. Ishida K, Hayashi H, Miyamoto A, Sugimoto Y, Ito M, Murakami Y, Horie M: P-wave and the development of atrial fibrillation. Heart Rhythm. 7(3): 289-294, 2010.
  7. Matsumoto T, Fujita M, Sawamura T, Kakino A, Sato Y, Fujita Y, Matsuda H, Nakanishi M, Uchida K, Nakae I, Kanda H, Yoshida A, Miwa K, Hayashi H, Mitsunami K, Horie M: Pitavastatin reduces Lectin-Like oxidized low-density lipoprotein Receptor-1 ligands in hypercholesterolemic humans. Lipids. 45(4): 329-335, 2010.
  8. Watanabe H, Makiyama T, Koyama T, Kannankeril PJ, Seto S, Okamura K, Oda H, Itoh H, Okada M, Tanabe N, Yagihara N, Kamakura S, Horie M, Aizawa Y, Shimizu W: High prevalence of early repolarization in short QT syndrome. Heart Rhythm. 7(5): 647-652, 2010.
  9. Constantino J, Long Y, Ashihara T, Trayanova NA: Tunnel propagation following defibrillation with ICD shocks: Hidden postshock activations in the left ventricular wall underlie isoelectric window. Heart Rhythm. 7(7): 953-961, 2010.
  10. Toyoda F, Ding W-G, Zankov DP, Omatsu-Kanbe M, Isono T, Horie M, Matsuura H: Characterization of the rapidly activating delayed rectifier potassium current, IKr, in HL-1 mouse atrial myocytes. J Membr Biol. 235(2): 73-87, 2010.
  11. Yasuda S, Hiramatsu S, Odashiro K, Maruyama T, Tsuji K, Horie M: A family of hereditary long QT syndrome caused by Q738X HERG mutation. Int J Cardiol. 144(1): 69-72, 2010.
  12. Yamamura K, Muneuchi J, Uike K, Ikeda K, Inoue H, Takahata Y, Shiokawa Y, Yoshikane Y, Makiyama T, Horie M, Hara T: A novel SCN5A mutation associated with the linker between III and IV domains of Nav1.5 in a neonate with fatal long QT syndrome. Int J Cardiol. 145(1): 61-64, 2010.
  13. Horie M: Bi-directional ventricular tachycardia revised. J Arrhythm. 26: 3-4, 2010.
  14. Itoh H, Shimizu W, Hayashi K, Yamagata K, Sakaguchi T, Ohno S, Makiyama T, Akao M, Ai T, Noda T, Miyazaki A, Miyamoto Y, Yamagishi M, Kamakura S, Horie M: Long QT syndrome with compound mutations is associated with a more severe phenotype: A Japanese multicenter study. Heart Rhythm. 7(10): 1411-1418, 2010.
  15. Matsumoto T, Takashima H, Nakae I, Yamane T, Hayashi H, Horie M; for the SPAIC (Shiga tissue Plasminogen Activator In Coronary circulation) Investigators: Angiotensin-converting enzyme inhibition augments coronary release of tissue plasminogen activator in women but not in men. Hypertension. 56(3): 364-368, 2010.
  16. Yoshino T, Nakae I, Matsumoto T, Mitsunami K, Horie M: Relationship between exercise capacity and cardiac diastolic function assessed by time-volume curve from 16-frame gated myocardial perfusion SPECT. Ann Nucl Med. 24(6): 469-476, 2010.
  17. Oka Y, Itoh H, Ding WG, Shimizu W, Makiyama T, Ohno S, Nishio Y, Sakaguchi T, Akashi M, Kawamura M, Matsuura H, Horie M: Atrioventricular block-induced Torsades de Pointes with clinical and molecular backgrounds similar to ongenital long QT syndrome. Circ J. 74(12): 2562-71, 2010.
  18. Nagaoka I, Shimizu W, Mizusawa Y, Sakaguchi T, Itoh H, Ohno S, Makiyama T, Yamagata K, Makimoto H, Miyamoto Y, Kamakura S, Horie M: Heart rate-dependent variability of cardiac events in type 2 congenital long-QT syndrome. Europace. 12(11): 1623-1629, 2010.
  19. Hayashi H, Miyamoto A, Ishida K, Yoshino T, Sugimoto Y, Ito M, Horie M: Prevalence and QT interval of early repolarization in a hospital-based population. J Arrhythm. 26(2): 127-133, 2010.
  20. Nakae I, Mitsunami K, Yoshino T, Omura T, Tsutamoto T, Matsumoto T, Morikawa S, Inubushi T, Horie M: Clinical features of myocardial triglyceride in different types of cardiomyopathy assessed by proton magnetic resonance spectroscopy: Comparison with myocardial creatine. J Card Fail. 16(10): 812-822, 2010.
  21. Yamaji M, Tsutamoto T, Kawahara C, Nishiyama K, Yamamoto T, Fujii M, Horie M: Effect of eplerenone versus spironolactone on cortisol and hemoglobin a1(c) levels in patients with chronic heart failure. Am Heart J. 160(5): 915-921, 2010.
  22. Makiyama T, Shizuta S, Akao M, Kimura T, Horie M. Genetic background of arrhythmic disorders: Genetic background of familial arrhythmic disorders. JPN. J. Electrocardiol. 30(3): 200-208, 2010.

このページの先頭へ

2009

  1. Ikrar T, Hanawa H, Watanabe H, Aizawa Y, Ramadan MM, Chinushi M, Horie M, Aizawa Y: Evaluation of channel function after alteration of amino acid residues at the pore center of KCNQ1 channel. BBRC. 378(3): 589-594, 2009.
  2. Kawamura M, Ozawa T, Yao T, Ashihara T, Sugimoto Y, Yagi T, Itoh H, Ito M, Makiyama T, Horie M: Dynamic change in ST-segment and spontaneous occurrence of ventricular fibrillation in Brugada syndrome with a novel nonsense mutation in the SCN5A gene during long-term follow-up. Circ J. 73(3): 584-588, 2009.
  3. Wu J, Ding WG, Matsuura H, Tsuji K, Zang WJ, Horie M: Inhibitory actions of the phosphatidylinositol 3-kinase inhibitor LY294002 on the human Kv1.5 channel. Brit J Pharm. 156(2): 377-387, 2009.
  4. Zankov DP, Yoshida H, Tsuji K, Toyoda F, Ding WG, Matsuura H, Horie M: Adrenergic regulation of the rapid component of delayed rectifier K+ current: Implications for arrhythmogenesis in LQT2 patients. Heart Rhythm. 6(7): 1038-1046, 2009.
  5. Itoh H, Sakaguchi T, Ashihara T, Ding G W, Nagaoka I, Oka Y, Nakazawa Y, Yao T, Jo H, Ito M, Matsuura H, Horie M: A novel KCNH2 mutation as a modifier for short QT interval. Int J Cardiol. 137(1): 83-85, 2009.
  6. Nakazawa Y, Ashihara T, Tsutamoto T, Ito M, Horie M: Endothelin-1 as a predictor of atrial fibrillation recurrence after pulmonary vein isolation. Heart Rhythm. 6(6): 725-730, 2009.
  7. Ohno S, Toyoda F, Zankov D, Yoshida H, Makiyama T, Tsuji K, Honda T, Obayashi K, Matsuura H, Shimizu W, Miyamoto Y, Kamakura S, Kita T, Horie M: Novel KCNE3 mutation reduces repolarizing potassium current and associated with long QT syndrome. Hum Mutat. 30(4): 557-563, 2009.
  8. Ogawa S, Yamashita T, Yamazaki T, Aizawa Y, Atarashi H, Inoue H, Ohe T, Ohtsu H, Okumura K, Katoh T, Kamakura S, Kumagai K, Kurachi Y, Kodama I, Koretsune Y, Saikawa T, Sakurai M, Sugi K, Tabuchi T, Nakaya H, Nakayama T, Hirai M, Fukatani M, Mitamura H; J-RHYTHM Investigators: Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study. Circ J. 73(2): 242-248, 2009.
  9. Yamashita T, Ogawa S, Sato T, Aizawa Y, Atarashi H, Fujiki A, Inoue H, Ito M, Katoh T, Kobayashi Y, Koretsune Y, Kumagai K, Niwano S, Okazaki O, Okumura K, Saku K, Tanabe T, Origasa H; J-BAF Investigators. Collaborators: Ito M, Ashihara T, Itoh H, Sugimoto Y: Dose-response effects of bepridil in patients with persistent atrial fibrillation monitored with transtelephonic electrocardiograms: a multicenter, randomized, placebo-controlled, double-blind study (J-BAF Study). Circ J. 73(6): 1020-1027, 2009.
  10. Zankov DP, Toyoda F, Omatsu-Kanbe M, Matsuura M, Horie M: Angiotensin II type 1 receptor mediates partially hyposmotic-induced increase of IKs current in guinea pig atrium. Pflugers Arch. 458(5): 837-849, 2009.
  11. Nishio Y, Makiyama T, Itoh H, Sakaguchi T, Ohno S, Gong Y-Z, Yamamoto S, Ozawa T, Ding W-G, Toyoda F, Kawamura M, Akao M, Matsuura H, Kita T, Horie M: D85N, a KCNE1 polymorphism, is a disease-causing gene variant in long QT syndrome. J Am Coll Cardiol. 54(9): 812-819, 2009.
  12. Tamaki S, Nakamura Y, Tabara Y, Okamura T, Kanda H, Kita Y, Kadowaki T, Tsujita Y, Chowdhury Turin T, Horie M, Miki T, Ueshima H: Association between polymorphism of the AGTR1 and cardiovascular events in a Japanese general sample (The Shigaraki Study). Int J Cardiol. 136(3): 354-355, 2009.
  13. Inoue H, Fujiki A, Origasa H, Ogawa S, Okumura K, Kubota I, Aizawa Y, Yamashita T, Atarashi H, Horie M, Ohe T, Doi Y, Shimizu A, Chishaki A, Saikawa T, Yano K, Kitabatake A, Mitamura H, Kodama I, Kamakura S: Prevalence of atrial fibrillation in the general population of Japan: An analysis based on periodic health examination. Int J Cardiol. 137(2): 102-107, 2009.
  14. Okamura T, Sekikawa A, Kadowaki T, El-Saed A, Abbott DR, Curb JD, Edmundowicz D, Nakamura Y, Murata K, Kashiwagi A, Sutton-Tyrrell K, Evans RW, Zmuda JM, Maegawa H, Hozawa A, Mitsunami K, Nisio Y,Miljkovic-Gacicl I, Horie M, Miyamatsu N, Murakami Y, Kuller LH, Ueshima H: Cholesteryl ester transfer protein, coronary calcium, and intima-media thickness of the carotid artery in middle-aged Japanese men. Am J Cardiol. 104(6): 818-822, 2009.
  15. Nishiyama K, Tsutamoto T, Tanaka T, Fujii M, Yamamoto T, Yamaji M, Horie M: Plasma NT-proBNP as a more reliable biomarker of endogenous cardiac natriuretic peptides Than BNP during carperitide infusion. Int Heart J. 50(2): 183-190, 2009.
  16. Yamaji M, Tsutamoto T, Tanaka T, Kawahara C, Nishiyama K, Yamamoto T, Fujii M, Horie M: Effect of carvedilol on plasma adiponectin concentration in patients with chronic heart failure. Circ J. 73(6): 1067-1073, 2009.
  17. Kamakura S, Ohe T, Nakazawa K, Aizawa Y, Shimizu A, Horie M, Ogawa S, Okumura K, Tsuchihashi K, Sugi K, Makita N, Hagiwara N, Inoue H, Atarashi H, Aihara N, Shimizu W, Kurita T, Suyama K, Noda T, Satomi K, Okamura H, Tomoike H: Long-term prognosis of probands with Brugada-pattern ST-Elevation in leads V1-V3. Circ Arrhythm Electrophysiol. 2(5): 495-503, 2009.
  18. Itoh H, Sakaguchi T, Ding WS, Watanabe E, Watanabe I, Nishio Y, Makiyama T, Ohno S, Akao M, Higashi Y, Zenda N, Kubota T, Mori C, Okajima K, Haruna T, Miyamoto A, Kawamura M, Ishida K, Nagaoka I, Oka Y, Nakazawa Y, Yao T, Jo H, Sugimoto Y, Ashihara T, Hayashi H, Ito M, Imoto K, Matsuura H, Horie M: Latent genetic backgrounds and molecular pathogenesis in drug-induced long QT syndrome. Circ Arrhythm Electrophysiol. 2(5): 511-523, 2009.
  19. Tsutamoto T, Kawahara C, Yamaji M, Nishiyama K, Fujii M, Yamamoto T, Horie M: Relationship between renal function and serum cardiac troponin T in patients with chronic heart failure. Eur J Heart Fail. 11(7): 653-658, 2009.
  20. Tsutamoto T, Tanaka T, Nishiyama K, Yamaji M, Kawahara C, Fujii M, Yamamoto T, Horie M: Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension. Hypertens Res. 32(8): 670-674, 2009.
  21. Yamaji M, Tsutamoto T, Kawahara C, Nishiyama K, Yamamoto T, Fujii M, Horie M: Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: The impact of oxidative stress. Circ Heart Fail. 2(6): 608-615, 2009.
  22. Nishiyama K, Tsutamoto T, Yamaji M, Kawahara C, Yamamoto T, Fujii M, Horie M: Dose- Dependent prognostic effect of carvedilol in patients with chonic heart failure: Special reference to ranscardiac gragient of norepinephrine. Circ J. 73(12): 2270-2275, 2009.
  23. Yamaji M, Tsutamoto T, Tanaka T, Kawahara C, Nishiyama K, Yamamoto T, Fujii M, Horie M: Effect of carperitide on plasma adiponectin levels in acute decompensated heart failure patients with diabetes mellitus. Circ J. 73(12): 2264-2269, 2009.
  24. Tsutamoto T, Yamaji M, Kawahara C, Nishiyama K, Fujii M, Yamamoto T, Horie M: Effect of simvastatin vs. rosuvastatin on adiponectin and haemoglobin A1c levels in patients with non-ischaemic chronic heart failure. Eur J Heart Fail. 11(12): 1195-1201, 2009.
  25. Furukawa Y, Ehara N, Taniguchi R, Haruna Y, Ozasa N, Saito N, Doi T, Hoshino K, Tamura T, Shizuta S, Abe M, Toma M, Morimoto T, Teramukai S, Fukushima M, Kita T, Kimura T; CREDO-Kyoto Investigators: Coronary risk factor profile and prognostic factors for young Japanese patients undergoing coronary revascularization. Circ J.73(8): 1459-1465.2009

このページの先頭へ

症例報告

このページの先頭へ

2008

  1. Ashihara T, Constantino J, Trayanova NA: Tunnel propagation of postshock activations as a unified hypothesis for fibrillation induction and isoelectric window. Circ Res. 102(6): 737-745, 2008.
  2. Harada M, Honjo H, Yamazaki M, Nakagawa H, Ishiguro Y, Okuno Y, Ashihara T, Sakuma I, Kamiya K, Kodama I: Moderate hypothermia increases the chance of spiral wave collision in favor of self termination of ventricular tachycardia/fibrillation. Am J Physiol Heart Circ Physiol. 294(4): H1896-H1905, 2008.
  3. Ijiri T, Ashihara T, Yamaguchi T, Takayama K, Igarashi T, Namba T, Shimada T, Haraguchi R, Nakazawa K: A procedural method for modeling the purkinje fibers of the heart. J Physiol Sci. 58(7): 481-486, 2008.
  4. Takayama K, Ashihara T, Ijiri T, Igarashi T, Haraguchi R, Nakazawa K: A sketch-based interface for modeling myocardial fiber orientation that considers the layered structure of the ventricles. J Physiol Sci. 58(7): 487-492, 2008.
  5. Matsumoto T, Fujita M, Tarutani Y, Yamane T, Takashima H, Nakae I, Horie M: Whole-body periodic acceleration enhances brachial endothelial function. Circ J. 72(1): 139-143, 2008.
  6. Ohno S, Kubota T, Yoshida H, Tsuji K, Makiyama T, Yamada S, Kuga K, Yamaguchi I, Kita T, Horie M: A novel mutation associated with Jervell and Lange-Nielsen syndrome in a Japanese family. Circ J. 72(5): 687-693, 2008.
  7. Sakaguchi T, Shimizu W, Itoh H, Noda T, Miyamoto A, Nagaoka I, Oka Y, Ashihara T, Ito M, Tsuji K, Ohno S, Makiyama T, Kamakura S, Horie M: Age- and genotype-specific triggers for life-threatening arrhythmia in the genotyped long-QT syndrome. J Cardiovasc Electrophysiol. 19(8): 794-799, 2008.
  8. Nagaoka I, Shimizu W, Itoh H, Yamamoto S, Sakaguchi T, Ashihara T, Ito M, Yoshida H, Ohno S, Miyamoto Y, Kamakura S, Akao M, Horie M: Mutation site dependent variability of cardiac events in LQT2 form of congenital long-QT syndrom. Circ J. 72(5): 694-699, 2008.
  9. Makiyama T, Akao M, Shizuta S, Doi T, Nishiyama K, Oka Y, Ohno S, Nishio Y, Tsuji K, Itoh H, Kimura T, Kita T, Horie M: A novel SCN5Again-of-function mutation M1875T associated with familial atrial fibrillation. J Am Coll Cardiol. 52(16): 1326-1334, 2008.
  10. Yasue H, Mizuno Y, Harada E, Itoh T, Nakagawa H, Nakayama M, Ogawa H, Tayama S, Honda T, Hokimoto S, Ohshima S, Hokamura Y, Kugiyama K, Horie M, Yoshimura M, Harada M, Uemura S, Saito Y: Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition on coronary spasm after withdrawal of Ca-channel blockers. J Am Coll Cardiol. 51(18): 1742-1748, 2008.
  11. Tsutamoto T, Tanaka T, Sakai H, Nishiyama K, Fujii M, Yamamoto T, Nakae I, Ohnishi M, Wada A, Horie M: Beneficial effect of perindopril on cardiac sympathetic nerve activity and brain natriuretic Peptide in patients with chronic heart failure. Circ J. 72(5): 740-746, 2008.
  12. Nakae I, Matsuo S, Matsumoto T, Mitsunami K, Horie M: Augmentation Index and Pulse Wave Velocity as Indicators of Cardiovascular Stiffness. Angiology. 59(4): 421-426, 2008. .
  13. Matsuo S, Nakajima K, Horie M, Nakae I, Nishimura T; The J-ACCESS Investigators: Prognostic Value of Normal Stress Myocardial Perfusion Imaging in Japanese Population. Circ J. 72(4): 611-617, 2008.
  14. Tanaka T, Tsutamoto T, Nishiyama K, Sakai H, Fujii M, Yamamoto T, Horie M: Impact of oxidative stress on plasma adiponectin in patients with chronic heart failure. Circ J. 72(4): 563-568, 2008.
  15. Tanaka T, Tsutamoto T, Sakai H, Nishiyama K, Fujii M, Yamamoto T, Horie M: Effect of atrial natriuretic peptide on adiponectin in patients with heart failure. Eur J Heart Fail. 10(4): 360-366, 2008.
  16. Tamaki S, Nakamura Y, Teramura M, Sakai M, 1, Takayama T, Okabayashi T, Kawashima T, Horie M: The factors contributing to whether or not hypertensive patients bring their home blood pressure record to the outpatient exam. Intern Med. 47(18): 1561-1565, 2008.
  17. Makiyama T, Akao M, Haruna Y, Tsuji K, Doi T, Ohno S, Nishio Y, Kita T, Horie M: Mutation analysis of the glycerol-3 phosphate dehydrogenase-1 like (GPD1L) gene in Japanese patients with Brugada syndrome. Circ J. 72(10): 1705-1706, 2008.
  18. Makita N, Behr E, Shimizu W, Horie M, Sunami A, Crotti L, Schulze-Bahr E, Fukuhara S, Mochizuki N, Makiyama T, Itoh H, Christiansen M, McKeown P, Miyamoto K, Kamakura S, Tsutsui H, Schwartz P J, George Jr.A, Roden D: The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest. 118(6): 2219-2229, 2008.
  19. Yamada H, Yoshida M, Nakano Y, Suganami T, Satoh N, Mita T, Azuma K, Itoh M, Yamamoto Y, Kamei Y, Horie M, Watada H, Ogawa Y: In vivo and in vitro inhibition of monocyte adhesion to endothelial cells and endothelial adhesion molecules by eicosapentaenoic acid. Arteroiscler Thromb Vasc Biol. 28(12): 2173-2179, 2008.
  20. Gong YZ, Ding WG, Wu J, Tsuji K, Horie M, Matsuura H: Cinnamyl-3, 4-dihydroxy-alpha-cyanocinnamate and nordihydroguaiaretic acid inhibit human Kv1.5 currents independently of lipoxygenase. Eur J Pharmacol. 600(1-3): 18-25, 2008.
  21. Takayama T, Teramura M, Sakai H, Tamaki S, Okabayashi T, Kawashima T, Yamamoto T, Horie M, Suzuki T, Asai T: Perforated mitral valve aneurysm associated with Libman-Sacks endocarditis. Intern Med. 47(18): 1605-1608, 2008.
  22. Nakae I, Matsuo S, Matsumoto T, Horie M: Clinical significance of diastolic function as an indicator of myocardial ischemia assessed by 16-frame gated myocardial perfusion SPECT. Ann Nucl Med. 22(8): 677-683, 2008.
  23. Inoue T, Eguchi Y, Matsumoto T, Kijima Y, Kato Y, Ozaki Y, Waseda K, Oda H, Seiki K, Node K, Urade Y: Lipocalin-type prostaglandin D synthase is a powerful biomarker for severity of stable coronary artery disease. Atherosclerosis. 201(2): 385-391, 2008.
  24. Sakaguchi T, Itoh H, Ding WG, Tsuji K, Nagaoka I, Oka Y, Ashihara T, Ito M, Yumoto Y, Zenda N, Higashi Y, Takeyama Y, Matsuura H, Horie M: Hydroxyzine, a first generation H1-receptor antagonist, inhibits human ether-a-go-go related gene (HERG) current and causes syncope in a patient with the HERG mutation. J Pharmacol Sci. 108(4): 462-471, 2008.
  25. Tsutamoto T, Nishiyama K, Sakai H, Tanaka T, Fujii M, Yamamoto T, Yamaji M, Horie M: Transcardiac increase in norepinephrine and prognosis in patients with chronic heart failure. Eur J Heart Fail. 10(12): 1208-1214, 2008.
  26. Horie M, Ishida K, Nishio Y, Nagaoka I, Matsui K: Genetic background of arrhythmogenic right ventricular dysplasia/Cardiomyopathy: Time to start asian registry. J Arrhythm. 24(4): 195-199, 2008.
  27. Matsuo S, Nakajima K, Kinuya S, Sato Y, Matsumoto N, Horie M: Cardiac scintigraphic findings of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: A case report. Exp Clin Cardiol. 13(2): 93-95, 2008.
  28. Furukawa Y, Taniguchi R, Ehara N, Ozasa N, Haruna Y, Saito N, Doi T, Hoshino K, Shizuta S, Morimoto T, Imai Y, Teramukai S, Fukushima M, Kita T, Kimura T; CREDO-Kyoto Investigators: Better survival with statin administration after revascularization therapy in Japanese patients with coronary artery disease: perspectives from the CREDO-Kyoto registry. Circ J. 73(12): 1937-1945, 2009.

このページの先頭へ

症例報告

このページの先頭へ

2007

  1. Ohno S, Zankov D, Yoshida H, Tsuji K, Makiyama T, Itoh H, Akao M, Hancox JC, Kita T, Horie M: N- and C-terminal KCNE1 mutations cause distinct phenotypes of long QT syndrome. Heart Rhythm. 4(3): 332-340, 2007.
  2. Tsuji K, Akao M, Ishii T, Ohno S, Makiyama T, Doi T, Haruna Y, Yoshida H, Nakashima T, Kita T, Horie M: Mechanistic basis for the pathogenesis of long QT syndrome caused by a splicing mutation in KCNQ1 gene. J Mol Cell Cardiol. 42(3): 662-669, 2007.
  3. Tsujita Y, Nakamura Y, Zhang Q, Tamaki S, Nozaki A, Amamoto K, Kadowaki T, Kita Y, Okamura T, Horie M, Ueshima H: The association between high-density lipoprotein cholesterol level and cholestery1 ester transfer protein TaqIB gene polymorphism is influenced by alcohol drinking in a population-based sample. Atherosclerosis. 191(1): 199-205, 2007.
  4. Nagatani Y, Takahashi M, Takazakura R, Nitta N, Murata K, Ushio N, Matsuo S, Yamamoto T, Horie M: Multidetector-row computed tomography coronary angiography: optimization of image reconstruction phase according to the heart rate. Circ J. 71(1): 112-121, 2007.
  5. Toda H, Ding WG, Yasuda Y.Toyoda F, Ito M, Matsuura H, Horie M: Stimulatory action of protein kinase Cvarepsilon isoform on the slow component of delayed rectifier K(+) current in guinea-pig atrial myocytes. Br J Pharmacol. 150(8): 1011-1021, 2007.
  6. Sakai H, Tsutamoto T, Ishikawa C, Tanaka T, Fujii M, Yamamoto T, Takashima H, Horie M: Direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP secretion and extent of coronary artery stenosis in patients with stable coronary artery disease. Circ J. 71(4): 499-505, 2007.
  7. Matsuo S, Nakae I, Tsutamoto T, Okamoto N, Horie M: A novel clinical indicator using Tc-99m sestamibi for evaluating cardiac mitochondrial function in patients with cardiomyopathies. J Nucl Cardiol. 14(2): 215-220, 2007.
  8. Itoh H, Tsuji K, Sakaguchi T, Nagaoka I, Oka Y, Nakazawa Y, Yao T, Jo H, Ashihara T, Ito M, Horie M, Imoto K: A paradoxical effect of lidocaine for the N406S mutation of SCN5A associated with Brugada syndrome. Int J Cardiol 2007;121:239-248.
  9. Takashima H, Matsumoto T, Nakae I, Yamane T, Horie M: Cigarette smoking impairs bradykinin-stimulated tissue plasminogen activator release in human coronary circulation. Thrombo Res. 120(6): 791-796. 2007.
  10. Todo T, Haraguchi R, Namba T, Yao T, Ashihara T, Higashi M, Inada H, Nakazawa K: Development of “Cardiac Arrhythmia Risk Evaluation” system based on computer simulation. Proc IEEE/ICME Int Conf Complex Med Eng. 182-185, 2007.
  11. Haraguchi R, Igarashi T, Owada S, Yao T, Namba T, Ashihara T, Ikeda T, Nakazawa K: Electrophysiological heart simulator equipped with sketchy 3-D modeling. Complex Medical Engineering: Springer-Verlag, 107-116, 2007.
  12. Tsutamoto T, Tanaka T, Sakai H, Ishikawa C, Fujii M, Yamamoto T, Horie M: Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure. Eur Heart J. 28(14): 1723-1730. 2007.
  13. Nakae I, Mitsunami K, Matsuo S, Horie M: Creatine Depletion and Altered Fatty Acid Metabolism in Diseased Human Hearts: Clinical Investigation Using (1)H Magnetic Resonance Spectroscopy and (123)I BMIPP Myocardial Scintigraphy. Acta Radiol. 48(4): 436-443, 2007.
  14. Tsutamoto T, Sakai H, Ishikawa C, Fujii M, Tanaka T, Yamamoto T, Takashima H, Ohnishi M, Wada A, Horie M: Direct comparison of transcardiac difference between brain natriuretic peptide (BNP) and N-terminal pro-BNP in patients with chronic heart failure. Eur J Heart Fail. 9(6-7): 667-673, 2007.
  15. Tsutamoto T, Sakai H, Tanaka T, Fujii M, Yamamoto T, Wada A, Ohnishi M, Horie M: Comparison of active renin concentration and plasma renin activity as a prognostic predictor in patients with heart failure. Circ J. 71(6): 915-921, 2007.
  16. Horie M, Ito H: Disorders of cardiac repolarization: Long QT and short QT syndromes. Circ J. 71 Suppl A: A50-A53. 2007.
  17. Lu J, Zhu SM, Zang WJ, Xu XL, Luo HL, Yu XJ, Wang SP, Kong SS, Wu J, Horie M, Sun L: Protective mechanism of adenosine to the rat arterial endothelial dysfunction induced by hydrogen peroxide. Biol Pharm Bull. 30(7): 1206-1211, 2007.
  18. Tanaka T, Tsutamoto T, Sakai H, Fujii M, Yamamoto T, Horie M: Effect of efonidipine versus amlodipine on aldosterone in patients with hypertension. Hypertens Res. 30(8): 691-697, 2007.
  19. Tsutamoto T, Asai S, Tanaka T, Sakai H, Nishiyama K, Fujii M, Yamamoto T, Ohnishi M, Wada A, Saito Y, Horie M: Plasma level of cardiotrophin-1 as a prognostic predictor in patients with chronic heart failure. Eur J Heart Fail. 9(10): 1032-1037, 2007.
  20. Tanaka T, Tsutamoto T, Sakai H, Fujii M, Yamamoto T, Horie M: Comparison of the effects of efonidipine and amlodipine on aldosterone in patients with hypertension. Hypertens Res. 30(8): 691-697, 2007.
  21. Crotti L, Spazzolini C, Schwartz P, Shimizu W, Denjoy I, Schulze-Bahr E, Zaklyazminskaya E, Swan H, Ackerman M, Moss A, Wilde A, Horie M, Brink P, Insolia R, Ferrari G, Crimi G: The common long QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: Toward a mutation-specific risk stratification. Circulation. 116(21): 2366-2375, 2007.
  22. Tsutamoto T, Sakai H, Nishiyama K, Tanaka T, Fujii M, Yamamoto T, Horie M: Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal proBNP and prognosis in patients with chronic heart failure. Circ J. 71(12): 1873-1878, 2007.
  23. Sumitomo N, Sakurada H, Taniguchi K, Matsumura M, Abe O, Miyashita M, Kanamaru H, Karasawa K, Ayusawa M, Fakamizu S, Nagaoka I, Horie M, Harada K, Hiraoka M: Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia. Circ J. 71(10): 1606-1609, 2007.
  24. Sugimoto T, Hajiro T, Fujimoto T, Kojyo N, Horie M, Kashiwagi A: Thrombotic microangiopathy in an adult patient with clinically amyopathic dermatomyositis complicated with interstitial lung disease. Lupus. 16(12): 1004-1005. 2007.
  25. Hayashi H, Shiferaw Y, Sato D, Nihei M, Lin S, Chen P, Garfinkel A, Weiss N J, Qu Z: Dynamic origin of spatially discordant alternans in cardiac tissue. Biophys J. 92(2): 448-460, 2007.
  26. Namba T, Haraguchi R, Igarashi T, Owada S, Yao T, Ashihara T, Todo T, Ikeda T, Nakazawa K: Development of graphical interface for modeling excitation map in the electrophysiological heart simulator. Proc IEEE/ICME Int Conf Complex Med Eng. 168-171, 2007.
  27. Namba T, Todo T, Yao T, Ashihara T, Haraguchi R, Nakazawa K, Ikeda T, Ohe T: Identification of local myocardial repolarization time by bipolar electrode potential. J Electrocardiol. 40(6 Suppl): S97-S102, 2007.
  28. Takagi M, Yokoyama Y, Aonuma K, Aihara N, Hiraoka M; for the Japan Idiopathic ventricular fibrillation study (J-IVFS) investigators: Clinical characteristics and risk stratification in symptomatic and asymptomatic patients with Brugada syndrome. J Cardiovasc Electrophysiol. 18(12): 1244-1251, 2007.
  29. Nakae I, Matsuo S, Tsutamoto T, Matsumoto T, Mitsunami K, Horie M: Assessment of cardiac function in patients with heart disease by quantitative gated myocardial perfusion SPECT. Ann Nucl Med. 21(6): 315-323, 2007.

このページの先頭へ

症例報告

このページの先頭へ

2006

  1. Dohke, Wada A, Isono T, Fujii M, Yamamoto T, Tsutamoto T, Horie M: Proteomic analysis reveals significant alternations of cardiac small heat shock protein expression in congestive heart failure. J Cardiac Fail. 12(1): 77-84, 2006.
  2. Hatada K, Washizuka T, Horie M, Watanabe H, Yamashita F, Chinushi M, Aizawa Y: Tumor necrosis factor-alpha inhibits the cardiac delayed rectifier K current via the asphingomyelin pathway. Biochem Biophys Res Commun. 344(1): 189-193, 2006.
  3. Ishikawa C, Tsutamoto T, Fujii M, Sakai H, Tanaka T, Horie M: Prediction of mortality by high-sensitivity C-reactive protein and brain natriuretic Peptide in patients with dilated cardiomyopathy. Circ J. 70(7): 857-863, 2006.
  4. Lu J, Nishi T, Ashihara T, Schnider N, Amano A, Matsuda T, Kotera H: The influence of activation time on the contraction force of myocardial tissue: A simulation study. Conf Proc IEEE Eng Med Biol Soc. 1: 2900-2903, 2006.
  5. Itoh H, Horie M, Ito M, Imoto K: Arrhythmogenesis in the short-QT syndrome associated with combined HERG channel gating defects: A simulation study. Circ J. 70(4): 502-508, 2006.
  6. Matsuo S, Nakae I, Matsumoto T, Horie M: Impact of endothelial dysfunction on left ventricular remodeling after successful primary coronary angioplasty for acute myocardial infarction: Analysis by quantitative ECG-gated SPECT. Ann Nucl Med. 20(1): 57-62, 2006.
  7. Matsuo S, Sato Y, Nakae I, Masuda D, Matsumoto N, Horie M: Evaluation of cardiac resynchronization therapy in drug-resistant dilated-phase hypertrophic cardiomyopathy by means of Tc-99m sestamibi ECG-gated SPECT. Ann Nucl Med. 20(9): 643-647, 2006.
  8. Nakae I, Matsuo S, Koh T, Mitsunami K, Horie M: Iodine-123 BMIPP scintigraphy in the evaluation of patients with heart failure. Acta Radiol. 47(8): 810-816, 2006.
  9. Ozawa T, Ito M, Tamaki S, Yao T, Ashihara T, Kita Y, Okamura T, Ueshima H, Horie M: Gender and age effects on ventricular repolarization abnormality in Japanese general carriers of G643S common single nucleotide polymorphism of KCNQ1 gene. Circ J. 70(6): 645-650, 2006.
  10. Sakai H, Tsutamoto T, Tsutsui T, Tanaka T, Ishikawa C, Horie M: Serum Level of Uric Acid, Partly Secreted From the Failing Heart, is a Prognostic Marker in Patients With Congestive Heart Failure. Circ J. 70(8): 1006-1011, 2006.
  11. Schwartz PJ, Spazzolini C, Crotti L, Bathen J, Denjoy I, Schulze-Bahr E, Amlie JP, Timothy K, Shkolnikova M, Berul C, Bitner-Glindzicz M, Toivonen L, Horie M: The Jervell and Lange-Nielsen Syndrome. Molecular basis, natural history, and clinical outcome. Circulation. 113: 783-790, 2006.
  12. Tamaki S, Nakamura Y, Tabara Y, Okamura T, Kita Y, Kadowaki T, Tsujita Y, Horie M, Miki T, Ueshima H: Relationship between metabolic syndrome and Trp64arg polymorphism of the beta-adrenergic receptor gene in a general sample: the Shigaraki study. Hypertens Res. 29(11): 891-896, 2006.
  13. Tamaki S, Nakamura Y, Yoshino T, Matsumoto Y, Tarutani Y, Okabayashi T, Kawashima T, Horie M: The association between morning hypertension and metabolic syndrome in hypertensive patients. Hypertens Res. 29(10): 783-788, 2006.
  14. Tsujita Y, Muraski J, Shiraishi I, Kato T, Kajstura J, Anversa P, Sussman MA: Nuclear Targeting of Akt Antagonizes Aspects of Cardiomyocyte Hypertrophy. Proc Natl Acad Sci U S A. 103(32): 11946-11951, 2006.
  15. Tsutamoto T, Wada A, Sakai H, Ishikawa C, Tanaka T, Hayashi M, Fujii M, Yamamoto T, Dohke T, Ohnishi M, Takashima H, Kinoshita M, Horie M: Relationship between renal function and plasma brain natriuretic Peptide in patients with heart failure. J Am Coll Cardiol. 47(3): 582-586, 2006.
  16. Yamane T, Matsumoto T, Nakae I, Takashima H, Tarutani Y, Tamaki S, Horie M: Impact of paraoxonase polymorphism (Q192R) on endothelial function in intact coronary circulation. Hypertens Res. 29(6): 417-422, 2006.
  17. Zhang CT, Yasuno S, Kuwahara K, Zankov D, Kobori A, Makiyama T, Horie M: Blockade of Angiotensin II type 1 receptor improves the arrhythmia morbidity in mice with left ventricular hypertrophy. Circ J. 70(3): 335-341, 2006.
  18. Zankov DP, Toyoda F, Ding WG, Matsuura H, Horie M: Angiotensin II potentiates IKs potassium current via AT1 receptors in guinea-pig atrial myocytes. Circulation. 113(10): 1278-1286, 2006.
  19. Zankov DP, Omatsu-Kanbe M, Toyoda F, Ding WG, Matsuura H, Isono T, Horie M: Response to letter regarding article, "Angiotensin II potentiates the slow component of delayed rectifier K+ Current via the AT1 receptor in guinea pig atrial myocytes". Circulation. 113(10): 1278-1286, 2006.
  20. Kinoshita H, Kuwahara K, Harada M, Horie M, Nakagawa Y, Nakanishi M, Usami S, Fujiwara M, Ueshima K, Nakao K. Blockade of T-type Calcium Channel Suppressed the Arrhythmogenicity in Dominant Negative NRSF Transgenic Mice. Journal of Cardiac Failure 12(8):S163, 2006.

このページの先頭へ

症例報告

このページの先頭へ

2005

  1. Aiba T, Shizimu W, Inagaki M, Noda T, Miyoshi S, Ding W-G, Zankov DP, Toyoda F, Matuura H, Horie M, Sunagawa K: Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil. J Am Coll Cardiol. 45(2): 300-307, 2005.
  2. Ashihara T, Trayanova NA: Cell and tissue responses to electric shocks. Europace. 7 Suppl 2: 155-165, 2005.
  3. Hamamoto T, Tanaka H, Mani H, Tanabe T, Fujiwara K, Nakagami T, Horie M, Oyamada M, Takamatsu T: In situ Ca2+ dynamics of Purkiinje fibers and its interconnection with subjacent ventricular myocytes. J Mol Cell Cardiol. 38(4): 561-569, 2005.
  4. Haraguchi R, Igarashi T, Owada S, Yao T, Namba T, Ashihara T, Ikeda T, Nakazawa K: Electrophysiological heart simulator equipped with sketchy 3-D modeling. Proc IEEE/ICME Int Conf Complex Med Eng. 293-296, 2005.
  5. Isikawa C, Tsutamoto T, Wada A, Fujii M, Ohno K, Sakai H, Yamamoto T, Horie M: Inhibition of aldosterone and endothelin-1 by carperitide was attenuated more than one week Infusion in patients with congestive heart failure. J Cardiovasc Pharmacol. 46(4): 513-518, 2005.
  6. Kato T, Muraski J, Chen Y, Tsujita Y, Wall J, Glembotski CC, Schaefer E, Beckerle M, Sussman MA: Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt. J Clin Invest. 115(10): 2716-2730, 2005.
  7. Makiyama T, Akao M, Tsuji K, Doi T, Ohno S, Takenaka K, Kobori A, Ninomiya T, Yoshida H, Takano T, Makita N, Yanagisawa F, Higashi Y, Takeyama Y, Kita T, Horie M: High-risk for bradyarrhythmic complications in patients with Brugada syndrome caused by SCN5A gene mutations. J Am Coll Cardiol. 46(11): 2100-2106, 2005.
  8. Matsuo S, Nakamura I, Yamada T, Uchida I, Nakae I, Horie M: Effect of statin therapy on arterial stiffness in patients with hyperlipidemia: Shiga pravastatin atherosclerosis study (SHIPAS) group. J Appl Res. 5: 397-401, 2005.
  9. Nakae I, Mitsunami K, Matsuo S, Inubushi T, Morikawa S, Tsutamoto T, Koh T, Horie M: Myocardial creatine concentration in various nonischemic heart diseases assessed by 1H magnetic resonance spectroscopy. Circ J. 69(6): 711-716, 2005.
  10. Nakae I, Mitsunami K, Matsuo S, Inubushi T, Morikawa S, Koh T, Horie M: Detection of calf muscle alterations in patients with chronic heart failure by 31P magnetic resonance spectroscopy: Impaired adaptation to continuous exercise. Exp Clin Cardiol. 10(1): 4-8, 2005.
  11. Nakae I, Matsuo S, Koh T, Mitsunami K, Horie M: Left ventricular systolic/diastolic function evaluated by quantitative ECG-gated SPECT: comparison with echocardiography and plasma BNP analysis. Ann Nucl Med. 19(6): 447-454, 2005.
  12. Nakae I, Matsuo S, Koh T, Mitsunami K, Horie M: Clinical significance of plasma BNP measurement in patients with psychiatric disease. International Med J. 12: 181-184, 2005.
  13. Tamaki S, Nakamura Y, Tabara Y, Okamura T, Kita Y, Kadowaki T, Tsujita Y, Horie M, Miki T, Ueshima H: Combined analysis of polymorphisms in angiotensinogen and adducin genes and their effects on hypertension in a Japanese population: The Shigaraki Study. Hypertens Res. 28(8): 645-650, 2005.
  14. Tanaka H, Hamamoto T, Takamatsu T: Toward an integrated understanding of the Purkinje fibers in the heart: the functional and morphological interconnection between the purkinje fibers and ventricular muscle. Acta Histochem Cytoc. 38: 257-265, 2005.
  15. Tarutani Y, Matsumoto T, Takashima H, Yamane T, Horie M: Brachial artery flow-mediated vasodilation is correlated with coronary vasomotor and fibrinolytic responses induced by bradykinin. Hypertens Res. 28(1): 59-66, 2005.
  16. Tsujita Y, Kato T, Sussman MA: Evaluation of left ventricular function in cardiomyopathic mice by tissue Doppler and color M-mode Doppler echocardiography. Echocardiography. 22(3): 245-253, 2005.
  17. Yao T, Ashihara T, Ito M, Nakazawa K, Horie M: Refractory gradient is responsible for the increase in ventricular vulnerability under sodium channel blockade. Circ J. 69(3): 345-353, 2005.
  18. Yasuda Y, Matuura H, Ito M, Matsumoto T, Ding W-G, Horie M: Regulation of the muscarinic K channel by extracellular ATP through membrane phosphatidylinositol 4, 5-biphsopahte in guinea-pig atrial myocytes. Br J Pharmacol. 145(2): 156-165, 2005.
  19. Zankov DP, Ding W-G, Matsuura H, Horie M: Open-state unblock characterizes acute inhibition of IKS potassium current by amiodarone in guinea-pig ventricular myocytes. J Cardiovasc Electrophysiol. 16(3): 314-322, 2005.
  20. Zhang L, Benson DW, Tristani-Firouzi M, Ptacek LJ, Tawil R, Schwartz PJ, George AL, Horie M, Andelfinger G, Snow GL, Fu Y-Ackerman MJ, Vincent GM: Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype. Circulation. 111(21): 2720-2726, 2005.

このページの先頭へ

症例報告

このページの先頭へ

2004

  1. Ashihara T, Trayanova NA: Asymmetry in membrane responses to electric shocks: Insights from bidomain simulations. Biophys J. 87(4): 2271-2282, 2004.
  2. Ashihara T, Namba T, Ito M, Ikeda T, Nakazawa K, Trayanova N: Spiral wave control by a localized stimulus: A bidomain model study. J Cardiovasc Electrophysiol. 15(2): 226-233, 2004.
  3. Ashihara T, Namba T, Ikeda T, Ito M, Nakazawa K, Trayanova N: Mechanisms of myocardial capture and temporal excitable gap during spiral wave reentry in a bidomain model. Circulation. 109(7): 920-925, 2004.
  4. Ashihara T, Trayanova NA: Shock-induced changes in transmembrane potential: What is the asymmetry due to? Insights from bidomain simulations. Advances in Electrocardiology: World Scientific, Singapore, 2004, pp. 143-147.
  5. Ashihara T, Trayanova NA: Mechanisms of shock-induced arrhythmogenesis: Role of tissue discontinuity and electroporation in the initiation of focal repetitive postshock activations. Advances in Electrocardiology: World Scientific, Singapore, 2004, pp. 832-836.
  6. Fujii M, Wada A, Ohnishi M, Tsutamoto T, Matsumoto T, Yamamoto T, Takayama T, Dohke T, Isono T, Eguchi Y, Horie M: Endogenous bradykinin suppresses myocardial fibrosis though the cardiac-genetated endothelin system under chronic angiotensin-converting enzyme inhibition in heart failure. J Cardiovasc Pharmacol. 44(Suppl.1): S346-S349, 2004.
  7. Kobori A, Sarai N, Shimizu W, Nakamura Y, Murakami Y, Makiyama T, Ohno S, Takenaka K, Ninomiya T, Fujiwara Y, Matsuoka S, Takano M, Noma A, Kita T, Horie M: Additional gene variants reduce effectiveness of beta-blockers in the LQT1 form of long QT syndrome. J Cardiovasc Electrophysiol. 15(2): 190-199, 2004.
  8. Matsumoto T, Takashima H, Ohira N, Tarutani Y, Yasuda Y, Yamane T, Matsuo S, Horie M: Plasma level of oxidized LDL is an independent determinant of coronary macro-and microvasomotor responses induced by bradykinin. J Am Coll Cardiol. 44(2): 451-457, 2004.
  9. Matsuo S, Matsumoto T, Nakae I, Ito M, Nakamura Y, Takada M, Murata K, Horie M: Evaluation of cardiac resynchronization therapy in drug-resistant idiopathic dilated cardiomyopathy by means of technetium-99m tetrofosmin electrocardiography-gated single-photon emmision computed tomography. Exp Clin Cardiol. 9(4): 248-250, 2004.
  10. Matsuo S, Matsumoto T, Takashima H, Ohira N, Yamane T, Yasuda Y, Tarutani Y, Horie M: The relationship between flow-mediated brachial artery vasodilation and coronary vasomotor responses to bradykinin: comparison with those to acetylcholine. J Cardiovasc Pharmacol. 44(2): 164-170, 2004.
  11. Matsuo S, Nakamura Y, Matsumoto T, Nakae I, Nagatani H, Takazakura R, Takahashi M, Murata K, Horie M: Visual assessment of coronary artery stenosis with electrocardiographically-gated multislice computed tomography. Int J Cardiovasc Imaging. 20(1): 61-66, 2004.
  12. Matsuo S, Matsumoto T, Nakae I, Koh T, Masuda D, Takada M, Murata K, Horie M: Prognostic value of ECG-gated thallium-201 single-photon emission tomography in patients with coronary artery disease. Ann Nucl Med. 18(7): 617-622, 2004.
  13. Nakae I, Mitsunami K, Yabe T, Inubushi T, Morikawa S, Matsuo S, Koh T, Horie M: Detection of metabolic abnormality in asynergic regions of ischemic human myocardium using 31P and 1H magnetic resonance spectroscopy. J Cardiovasc Magn Reson. 6(3): 685-696, 2004.
  14. Nakae I, Mitsunami K, Matsuo S, Matsumoto T, Morikawa S, Inubushi T, Koh T, Horie M: Assessment of myocardial creatine concentration in dysfunctional human heart by proton magnetic resonance spectroscopy. Magn Reson Med Sci. 3(1): 19-25, 2004.
  15. Nakamura Y, Tamaki S, Uchida Y, Ohmichi N, Yamaoka O, Miyauchi N, Fukuhara T, Sayama H, Yamada T, Matsuo S, Yamada Y: Angiotensin converting enzyme genotype influences the response to the angiotensin II receptor antagonist losartan in patients with hypertension. Hypertens Res. 27(3): 137-140, 2004.
  16. Niimi A, Matsumoto H, Takemura M, Ueda T, Nakano Y, Mishima M: Clinical assessment of airway remodeling in asthma: utility of computed tomography. Clin Rev Allergy Immunol. 27(1): 45-58, 2004.
  17. Ohira N, Matsumoto T, Tamaki S, Takashima H, Tarutani Y, Yamane T, Yasuda Y, Horie M: Angiotensin-converting enzyme insertion / deletion polymorphism modulates coronary release of tissue plasminogen activator in response to bradykinin. Hypertens Res. 27(1): 39-45, 2004.
  18. Ozawa T, Ito M, Tamaki S, Yao T, Ashihara T, Kita Y, Ueshima H, Horie M: Ventricular repolarization abnormality in Japanese carriers of G643S single nucleotide polymorphism of KCNQ1 gene. Advances in Electrocardiology: World Scientific, Singapore, 2004, pp. 131-133.
  19. Shimizu W, Horie M, Ohno S, Takenaka K, Yamaguchi M, Shimizu M, Washizuka T, Aizawa Y, Nakamura K, Ohe T, Aiba T, Miyamoto Y, Yoshimasa Y, Towbin J, Priori S, Kamakura S: Mutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulaion in the LQT1 Form of congenital long QT syndrome. J Am Coll Cardiol. 44(1): 117-125, 2004.
  20. Takayama T, Wada A, Tsutamoto T, Ohnishi M, Fujii M, Isono T, Horie M: Contribution of vascular NAD(P)H oxidase to endothelial dysfunction in heart failure and the therapeutic effects of HMG-CoA reductase inhibitor. Circ J. 68(11): 1067-1075, 2004.
  21. Tsutamoto T, Sakai H, Wada A, Ishikawa C, Ohno K, Fujii M, Yamamoto T, Takayama T, Dohke T, Horie M: Torasemide inhibits transcardiac extraction of aldosterone in patients with congestive heart failure. J Am Coll Cardiol. 44(11): 2252-2253, 2004.
  22. Tsutamoto T, Wada A, Ohnishi M, Tsutsui T, Ishii C, Ohno K, Fujii M, Matsumoto T, Yamamoto T, Takayama T, Dohke T, Horie M: Transcardiac increase in tumor necrosis factor-alpha and left ventricular end-diastolic volume in patients with dilated cardiomyopathy. Eur J Heart Fail. 6(2): 173-180, 2004.
  23. Yamamoto T, Wada A, Tsutamoto T, Ohnishi M, Horie M: Long-term treatment with a phosphodiesterase type 5 inhibitor improves pulmonary hypertension secondary to heart failure through enhancing the natriuretic peptides-cGMP pathway. J Cardiovasc Pharmacol. 44(5): 596-600, 2004.
  24. Yasumura Y, Miyatake K, Okamoto H, Miyauchi T, Kawana M, Tsutamoto T, Kitakaze M, Matsubara H, Takaoka H, Anzai T, Himeno H, Yokoyama H, Yokoya K, Shintani U, Hashimoto K, Koretsune Y, Nakamura Y, Imai K, Maruyama S, Masaoka Y, Sekiya M, Shiraki T, Shinohara H, Ozono K, Matsuoka T, Miyao Y, Nomura F: Rationale for the use of combination angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker therapy in heart failure. Circ J. 68(4): 361-366, 2004.
  25. Yumoto Y, Horie M, Kubota T, Ninomiya T, Kobori A, Takenaka K, Takano M, Niwano S, Izumi T: Bepridil block of recombinant human cardiac IKs current shows a time-dependent unblock. J Cardiovasc Pharmacol. 43: 178-182, 2004.

このページの先頭へ

症例報告

このページの先頭へ

2003

  1. Ashihara T, Namba T, Yao T, Ozawa T, Kawase A, Ikeda T, Nakazawa K, Ito M: Vortex cordis as a mechanism of postshock activation: Arrhythmia induction study using a bidomain model. J Cardiovasc Electrophysiol. 14(3): 295-302, 2003.
  2. Kawase A, Ikeda T, Nakazawa K, Ashihara T, Namba T, Kubota T, Sugi K, Hirai H: Widening of the excitable gap and enlargement of the core of reentry during atrial fibrillation with a pure sodium channel blocker in canine atria. Circulation. 107(6): 905-910, 2003.
  3. Hayashi M, Tsutamoto T, Wada A, Tsutsui T, Ishii C, Ohno K, Fujii M, Taniguchi A, Hamatani T, Nozato Y, Kataoka K, Morigami N, Ohnishi M, Kinoshita M, Horie M: Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction. Circulation. 107(20): 2559-2565, 2003.
  4. Horie M, Takenaka K, Ai T, Haruna T, Kono Y, Yoshida H, Kubota T, Ninomiya T, Kobori A, Ono S, Makiyama S, Otani and Takano M, Takaki H, Kamakura S, Shimizu W: Potassium Channels and Channelopathy-Clinical Cardiac Pacinc and Electrophysiology: Monduzzi Editore, 347-349, 2003.
  5. Katsuta H, Ozawa S, Ninomiya T, Shimoyama T, Ito E, Tanaka T, Yamaguchi S, Katahira H, Nagamatsu S, Horie M, Ishida H: Insulinotropic action of glutamate is dependent on the inhibition of ATP-sensitive potassium channel activities in MIN6 beta cells. Biochem Biophys Res Commun. 311(3): 660-664, 2003.
  6. Konishi H, Nishio S, Tsutamoto T, Minouchi T, Yamaji A: Serum carvediol concentation and its relation to change in plasma brain natriuretic peptide level in the treatment of heart failure: a preliminary study. Int J Clin Pharmol Ther. 41(12): 578-586, 2003.
  7. Kuwahara K, Saito Y, Takano M, Arai Y, Yasuno S, Nakagawa Y, Takahashi N, Adachi Y, Takemura G, Horie M, Miyamoto Y, Morisaki T, Kuratomi S, Noma A, Fujiwara H, Yoshimasa Y, Kinoshita H, Kawakami R, Kishimoto I, Nakanishi M, Usami S, Saito Y, Harada M, Nakao K: NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function. EMBO J. 22(23): 6310-6321, 2003.
  8. Matsumoto T, Minai K, Horie H, Ohira N, Takashima H, Tarutani Y, Yasuda Y, Ozawa T, Matsuo S, Kinoshita M, Horie M: Angiotensin-converting enzyme inhibition but not angiotensin II type 1 receptor antagonism augments coronary release of tissue plasminogen activator in hypertensive patients. J Am Coll Cardiol. 41(8): 1373-1379, 2003.
  9. Matsumoto T, Wada A, Tsutamoto T, Ohnishi M, Isono T, Kinoshita M: Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure. Circulation. 107(20): 2555-2558, 2003.
  10. Matsuo S, Matsumoto T, Nakae I, Takashima H, Nakamura Y, Horie M: Non-invasive detection of endothelial dysfunction in femoral artery using thallium-201 scintigraphy. International Med J. 10: 39-42, 2003.
  11. Matsuo S, Nakamura Y, Kinoshita M, Horie M: Plasma B-type natriuretic peptide measurement in asymptomatic population. International Med J. 10: 105-108, 2003.
  12. Matsuo S, Nakamura Y, Matsumoto T, Nakae I, Murata K, Horie M: Prognostic value of iodine-123 metaiodobenzylguanidine imaging in patients with heart failure. Exp Clin Cardiol. 8(2): 95-98, 2003.
  13. Nakae I, Matsumoto T, Omura T, Takashima H, Ohira N, Tarutani Y, Yasuda Y, Matsuo S, Koh T, Nakamura Y, Kinoshita M, Horie M: Endothelial modulation and tolerance development in the vasorelaxant responses to nitrate of rabbit aorta. Life Science. 73(24): 3083-3094, 2003.
  14. Nakae I, Mitsunami K, Omura T, Yabe T, Tsutamoto T, Matsuo S, Takahashi M, Morikawa S, Inubushi T, Nakamura Y, Kinoshita M, Horie M: Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy. J Am Coll Cardiol. 42(9): 1587-1593, 2003.
  15. Ninomiya T, Takano M, Haruna T, Kono Y, Horie M: Verapamil, a Ca2+ entry blocker, targets the pore-forming subunit of cardiac type KATP channel (Kir6.2). J Cardiovasc Pharmacol. 42(2): 161-168, 2003.
  16. Sekikawa A, Horiuchi BH, Edmundowicz D, Ueshima H, Curb DJ, Kim ST, Okamura T, Kadowaki T, Kashiwagi A, Mitsunami K, Nakamura Y, Murata K, Kuller LH, Okamura T: A "natural experiment" in cardiovascular epidemiology in the early-21st century. Heart. 89(3): 255-257, 2003.
  17. Takenaka K, Ai T, Shimizu W, Kobori A, Ninomiya T, Otani H, Kubota T, Takaki H, Kamakura S, Horie M: Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long QT syndrome. Circulation. 107(6): 838-844, 2003.
  18. Tsutamoto T, Tsutsui T, Maeda K, Hayashi M, Wada A, Ohnishi M, Fujii M, Ishii C: Effects of long-acting calcium channel antagonists on neurohumoral factors: comparison of nifedipine coat-core with amlodipine. J Cardiovasc Pharmacol. 41 Suppl 1: S77-81, 2003.
  19. Tsutamoto T, Wada A, Hayashi M, Tsutsui T, Maeda K, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Yamatoto T, Takayama T, Ishii C, Kinoshita M: Relationship between transcardiac gradient of endothelin-1 and left ventricular remodelling in patients with first anterior myocardial infarction. Eur Heart J. 24(4): 346-355, 2003
  20. Tsutamoto T, Wada A, Maeda K, Hayashi M, Tsutsui T, Ohnishi M, Fujii M, Matsumoto T, Yamamoto T, Takayama T, Ishii C: Transcardiac gradient of aldosterone before and after spironolactone in patients with congestive heart failure. J Cardiovasc Pharmacol. 41 Suppl 1: S19-22, 2003.

このページの先頭へ

症例報告

このページの先頭へ

 

このページの先頭へ